$AXON Licenses Investigational Gene Therapy for Parkinson’s Disease

• Exclusive worldwide license to lentiviral vector gene therapy constitutes the first transaction of Axovant’s 2018 pipeline expansion
• Fraser Wright, Co-Founder and former Chief Technology Officer of Spark Therapeutics, to join Axovant as CTO for gene therapy programs
• Axovant will receive $25 million equity financing from Roivant Sciences to support clinical development of AXO-Lenti-PD and additional business development
• Conference call / webcast today at 8:00am Eastern Time

BASEL, Switzerland, June 06, 2018 (GLOBE NEWSWIRE) — Axovant Sciences (NASDAQ:AXON) today announced that it has licensed the exclusive worldwide rights to develop and commercialize OXB-102, now AXO-Lenti-PD, from Oxford BioMedica. AXO-Lenti-PD is an investigational gene therapy for Parkinson’s disease that delivers three genes encoding a critical set of enzymes required for dopamine synthesis in the brain. Oxford BioMedica is a world leader in lentiviral vector product development and manufacturing, and will be the clinical and commercial supplier of AXO-Lenti-PD. Axovant expects to initiate a Phase 1/2 dose escalation study of AXO-Lenti-PD in patients with advanced Parkinson’s disease by the end of 2018.

Under the terms of the license agreement with Oxford BioMedica, Axovant obtained rights to AXO-Lenti-PD, as well as its predecessor product ProSavin®, for an initial payment of $30 million in cash, $5 million of which will be applied as a credit against the process development work and clinical supply that Oxford BioMedica will provide to Axovant. Oxford BioMedica is also eligible to receive additional development, regulatory, and commercial milestone payments potentially in excess of $812 million, and tiered royalties on net sales of AXO-Lenti-PD, if approved. Roivant has agreed to purchase $25 million of Axovant common shares, which will support the clinical development of AXO-Lenti-PD and additional business development activities.

Fraser Wright, PhD, will join Axovant as Chief Technology Officer overseeing the company’s gene therapy initiatives. Dr. Wright is the Co-Founder and former Chief Technology Officer of Spark Therapeutics and has over 20 years of leadership experience in the development of novel vector-based biologic products. At Spark he oversaw process development and clinical-stage manufacturing for LUXTURNA™. Prior to Spark, he was the founding Scientific Director of the Clinical Vector Core Laboratory at The Children’s Hospital of Philadelphia, where he directed clinical core staff in gene therapy investigational product development, manufacture, and quality control testing for ten first-in-human viral vector investigational products including LUXTURNA™ and Kymriah®. He was also previously the Director of Development and Clinical Manufacturing at Avigen. Dr. Wright was formerly a Research Professor of Pathology and Laboratory Medicine at the University of Pennsylvania School of Medicine, and he is the lead inventor on numerous issued patents during his time in that role. He received his BSc and PhD in biochemistry from the University of Toronto, where he was also an assistant professor of biochemistry and medicine.

Pavan Cheruvu, MD, Chief Executive Officer of Axovant, stated: “Axovant remains committed to developing innovative treatments for serious neurodegenerative conditions such as Parkinson’s disease, and we are excited to partner with Oxford BioMedica, a recognized global leader in cell and gene therapy. We are also pleased to welcome Fraser to our leadership team. He brings over two decades of experience in gene therapy manufacturing, and will be committed to building world-class gene therapy capabilities at Axovant. We will continue to pursue promising new therapeutic approaches based on transformative science, and will further expand our pipeline with high-quality assets like AXO-Lenti-PD. This is part of our long-term goal of building Axovant into a leader in the development and commercialization of innovative new medicines for neurological indications.”

“This is an exciting time to join Axovant, and I look forward to the opportunity to work closely with Oxford BioMedica and help build gene therapy capabilities at Axovant,” said Dr. Wright. “AXO-Lenti-PD is a strong foundation for Axovant’s new pipeline, and I am excited to begin preparing the Phase 1/2 clinical study in advanced Parkinson’s disease later this year.”

Commenting on the announcement, John Dawson, Chief Executive Officer of Oxford BioMedica said: “We are delighted to sign this significant agreement which not only underlines our LentiVector®-enabled platform and product development strategy but further demonstrates Oxford BioMedica’s ability to build multiple partnerships with leaders in their respective therapeutics fields. We believe Axovant’s expertise and focus on neurological disorders, which includes Parkinson’s disease, makes them an ideal development and commercialisation partner for this programme. Coupled with strong support and financial resources from parent company Roivant, we believe Axovant is well positioned to advance the development of AXO-Lenti-PD for the treatment of patients with Parkinson’s, a disease which still has a high unmet need.”

Teleconference/Webcast Details

To participate in the live conference call today, June 6, at 8:00 a.m. EDT, please dial 1-833-652-5918 from the U.S. and Canada or +1 409-767-9227 internationally, and use the passcode 8289429.

The live call is being webcast and can be accessed on the “Events and Presentations” page of the “Investors” section of the Company’s website at http://investors.axovant.com. A replay of the webcast will be available for 30 days following the live event.

About AXO-Lenti-PD

AXO-Lenti-PD, formerly OXB-102, is an investigational gene therapy for Parkinson’s disease that delivers three genes encoding a critical set of enzymes required for dopamine synthesis in the brain and is designed to provide patient benefit for multiple years following a single administration. AXO-Lenti-PD is a next-generation gene therapy with a modified payload configuration of the predecessor product, ProSavin®, to further improve endogenous dopamine production. Oxford BioMedica has successfully completed a Phase 1/2 study for ProSavin®, which met its primary endpoint. The results, which were published in The Lancet in 2014, demonstrate favorable safety and tolerability and a statistically significant improvement of motor function as measured by the UPDRS Part III score at 6 and 12 months. This improvement was sustained in most patients for up to four years despite the progressively degenerative nature of Parkinson’s disease.

About Parkinson’s Disease

Parkinson’s disease is caused by degeneration of nerve cells in a portion of the brain called the substantia nigra which leads to a reduction in dopamine. Low dopamine causes nerve cells to activate without normal control. Characteristic Parkinson’s disease symptoms include tremor, limb rigidity, slow physical movement, and gait and balance issues. Approximately one million Americans live with Parkinson’s disease, with 60,000 diagnosed each year. The combined direct and indirect cost of Parkinson’s disease, including treatment, Social Security payments, and lost income, is estimated to be nearly $25 billion per year in the United States alone.

About Axovant Sciences

Axovant is a clinical-stage biopharmaceutical company dedicated to advancing innovative treatments for patients with serious neurologic and neuropsychiatric conditions, and turning promising therapies into lasting solutions for patients. Axovant is committed to developing and commercializing a pipeline of product candidates by identifying and developing novel treatments for unmet needs in neurology and psychiatry.

About Oxford BioMedica

Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the “Group”) have built a sector-leading lentiviral vector delivery platform (LentiVector®), which the Group leverages to develop in vivo and ex vivo products both in-house and with partners. The Group has created a valuable proprietary portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders. The Group has also entered into a number of partnerships, including with Novartis to manufacture Kymriah®, Bioverativ, Sanofi, GSK, Orchard Therapeutics, GC LabCell and Immune Design, through which it has long-term economic interests in other potential gene and cell therapy products. Oxford BioMedica is based across several locations in Oxfordshire, UK and employs more than 320 people.

About Roivant Sciences

Roivant Sciences is a global biopharmaceutical company focused on reducing the time and cost of the drug development process to improve the lives of patients and their families. Roivant partners with innovative biopharmaceutical companies and academic institutions to ensure that important medicines are rapidly delivered to patients.

Forward-Looking Statements and Information

This press release contains forward-looking statements, including statements regarding Axovant’s plans to advance the development of AXO-Lenti-PD and expand its pipeline. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: risks associated with the ability to identify and in-license or acquire product candidates, and the success, cost, and timing of Axovant’s product development activities and any planned clinical trials. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Axovant’s business in general, see the “Risk Factors” section of Axovant’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (SEC) on February 9, 2018, and other filings that Axovant makes with the SEC from time to time. These forward-looking statements are based on information available to Axovant as of the date of this press release and speak only as of the date of this release. Axovant disclaims any obligation to update these forward-looking statements, except as may be required by law.

Financial details regarding this transaction will be provided in Axovant’s Form 8-K to be filed with the SEC. All trademarks are property of their respective owners.

Contacts:

Investors

Tricia Truehart
(631) 892-7014
investors@axovant.com

Media

Paul Davis
(646) 495-5310
media@axovant.com

$VSQTF Incorporates Blockchain Technology into Various Markets

NetworkNewsWire Editorial Coverage: The freelance employment market now comprises 34 percent of the United States workforce, according to a recent report, with freelance workers contributing approximately $1.4 trillion to the nation’s economy (http://nnw.fm/ZLkg1). Intrinsically connected with today’s freelance market, digital services has a compound annual growth rate of 6 percent and may be poised to become one of the next global economic drivers. Blockchain is a revolutionary technology that has the potential to fuel the growth of the digital freelance services market by enabling secure, transparent and rapid transactions. Companies bringing “Blockchain” to new industries include Bitcoin Investment Trust (OTC: GBTC), MGT Capital Investments, Inc. (OTCQB: MGTI), HIVE Blockchain Technologies Ltd.  (OTC: HVBTF) (TSX-V: HIVE), Global Blockchain Technologies Corp. (OTC: BLKCF) (CSE: BLOC) and Victory Square Technologies, Inc. (OTC: VSQTF) (CSE: VST) (VSQTF Profile).

Forbes reported that the next great area of blockchain disruption in 2018 could be the online freelancing business (http://nnw.fm/iJ6DM). Blockchain startups that spot this potentially profitable market gap are already popping up on the digital map. Capaciti, the professional services marketplace of parent company Howyl Ventures — which was recently acquired in part by Victory Square Technologies (OTC: VSQTF) (CSE: VST) — is poised to potentially be a big disruptor in the digital freelance space (http://nnw.fm/92N0u).

Targeting launch in Q3 of this year, Capaciti will be the world’s first blockchain-based, enterprise-grade marketplace for digital design and technology development services. With platform transactions projected to reach $36.9 million in 2019 and to surge to over $495 million by 2022, Capaciti looks like it is setting the stage for a billion-dollar show.

Capaciti’s application of blockchain technology upgrades an online marketplace from a manual, analog process to a decentralized, automated marketplace. This innovation could create the foundation for the next evolution of connecting talent and clients in the digital marketplace.

The market for Victory Square Technologies’ Capaciti’s initial service offering is substantial. In the United States alone, the software development market is estimated at over $235 billion per year, with 70 percent of that spend flowing to outsourced partners or freelance professionals.

The world’s workforce has become decentralized, and digital services business connections are now mostly made in online marketplaces. Freelancing is predicted to become the workforce majority within a decade (http://nnw.fm/zVJ6d). Upwork​, arguably the world’s largest and most successful online marketplace for freelance services, generates $1.5 billion per year in revenues and is targeting $10 billion in annual revenue by 2022. 99Designs reports a design upload occurs every second, and designers have made over $200 million on the site from over 444,000 clients.

Capaciti’s incubator, Victory Square Technologies, has a management team of established leaders in blockchain technology and digital marketplaces. The company was named one of the top 14 blockchain companies to watch in 2018 by Entrepreneur.com (http://nnw.fm/9xCil). CEO Shafin Diamond Tejani was named Canadian Angel Investor of the Year in 2017. Tejani has also launched more than 40 startups and has generated over $100 million in revenues per year.

Capaciti co-founders Marc Low, Steve Davis and Gary Bode have a successful track record of delivering projects using a distributed workforce model for big brands such as HCL Technology, Barclays Bank, Sotheby’s, Pacific Union International and Estee Lauder. They have collectively launched the global talent crowdsourcing platform Deloitte Pixel, held a senior marketing role at Apple and grown the team at Chimp Technology from five people to more than 70.

Victory Square Technologies’ Capaciti could potentially disrupt this trillion-dollar market that is in serious need of a technology upgrade.

Major Money Markets Ripe for Disruption

Capaciti’s freelance software development platform alone breaks into a $237 billion market. With plans to expand into additional service verticals, Victory Square Technologies new acquisition may have spotted a massive untapped reservoir of enterprise-grade business. Marketplaces such as Upwork, 99designs and Fiverr service some of the need but remain challenged in areas that can create a price squeeze in a hypercompetitive environment. Price squeezes can drive down profit margins to unsustainable levels for vendors.

Small-business clients often mine these sites to find workers for the lowest possible rate. Business relationships in online project marketplaces can start off well but end badly, with losses being cut on both sides. Workers pressure clients into payment for incomplete or insufficient work or want to move off the contracting platform to communicate and transact.

These markets, then, are arguably ripe for disruption.

Decluttering and De-risking the Online Marketplace

Victory Square Technologies’ Capaciti’s model pairs top-tier enterprise clients with top-tier talent to effectively deliver projects, creating an exchange that removes many risk elements.

Capaciti’s business model moderates business relationships in the online marketplace.  Rather than just creating a job board on which to post and pitch, participants on the platform vet the profiles and reputations of both freelancers and clients. Capaciti solves the mystery of who the clients and vendors are and what they do best. The company has designed a system for executing enterprise-level projects in a way that avoids the pitfalls of overpricing and delivery disagreements.

A blockchain-based reputation management protocol empowers vendors to earn a transparent and auditable “reputation score.” Blockchain smart contracts are used to manage contractual obligations between client and vendor and increase the speed and efficiency with which freelancers get paid for work performed, as payment settlements are transferred instantly upon successful completion.

With blockchain technology, a global reach and a laser focus on user retention, Victory Square Technologies’ Capaciti could potentially upstage companies such as Upwork, 99designs and Fiverr.

A Tech Vertical Fueled for Hypergrowth

The Capaciti platform is already being used internally by Victory Square Technologies to service existing client work and, once launched publicly, could be well-positioned to scale rapidly. First launching in the North American market, Capaciti will begin expansion into key markets in Europe and Asia next year. Victory Square Technologies’ investment in Capaciti sets the stage for success for this technology-driven vertical, already poised for growth and slated to launch soon with transactions projected in the millions straight out of the gate.

Potential Comparables:

Bitcoin Investment Trust (OTC: GBTC) is a traditional investment vehicle with shares titled in the investors’ names, providing a familiar structure for financial and tax advisors and easy transferability to beneficiaries under estate laws. Shares of the Bitcoin Investment Trust are eligible to be held in certain IRA, Roth IRA, and other brokerage and investor accounts.

MGT Capital Investments, Inc. (OTC: MGTI) is based in Durham, North Carolina, and ranks as one of the largest United States-based bitcoin miners. The company also has expanded facilities in Washington State and in Sweden.

HIVE Blockchain Technologies Ltd. (OTC: HVBTF) (TSX-V: HIVE) is building a bridge from the blockchain sector to traditional capital markets. HIVE is strategically partnered with Genesis Mining Ltd., the world’s leading cryptocurrency mining hashrate provider, to build the next generation of blockchain infrastructure. HIVE also owns a state-of-the-art GPU-based cryptocurrency mining facility in Iceland.

Global Blockchain Technologies Corp. (OTC: BLKCF) (CSE: BLOC) provides investors access to a mixture of assets in the blockchain space, strategically chosen to balance stability and growth. Blue chip holdings such as Ethereum and Bitcoin are complemented by best-of-breed “smaller cap” crypto holdings, many of which are not yet available to other investors.

Big Opportunities in Online Project Network

The over-trillion-dollar digital services market is clearly on an upward trajectory, and the online project-based network represents an opportunity for blockchain incubators such as Victory Square Technologies.

For more information on Victory Square Technologies Inc. (OTC:VSQTF) (CSE:VST), please visit StreetSignals.com for the FULL report.

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.  The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.

$CIIX Enters Into a Licensing Partnership With The Bad Crypto Podcast

NEW YORK, June 5, 2018 —

ChineseInvestors.com, Inc. (OTCQB: CIIX) (“CIIX” or the “Company”), the premier financial information website for Chinese-speaking investors, today announced that it has entered into a licensing partnership with The Bad Crypto Podcast to re-distribute the podcast’s most popular interviews on http://www.newcoins168.com , in Chinese.

Interviews that will be translated into Chinese for re-distribution on http://www.newcoins168.com include: Charlie Lee, Founder and Developer of Litecoin, Roger Ver, also known as ‘Bitcoin Jesus’, and Patrick Bryne, Overstock.com CEO and Founder of tZERO. In addition to re-distributing these informative interviews in Chinese, the Company’s CEO Warren Wang also appeared once again for an interview on The Bad Crypto Podcast on May 23, 2018. Mr. Wang first appeared on The Bad Crypto Podcast in December 2017 where he offered his perspective and insights on bitcoin and cryptocurrency in China.

“Since it first aired in July 2017, The Bad Crypto Podcast hosted by Joel Comm, Bitcoin Evangelist and Travis Wright, Blockchain Entrepreneur, has become a worldwide phenomenon with over 150 episodes for curious individuals trying to figure out cryptocurrency, blockchain and the future of digital payments,” says ChineseInvestors.com, Inc. CEO Warren Wang. “We are confident that this lighthearted, entertaining programming offered in Chinese will be well received by viewers looking to expand their crypto knowledge whether they are newbies or more experienced crypto investors.”

About ChineseInvestors.com (OTCQB: CIIX)

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail, online and direct sales of hemp-based products and other health related products.

For more information visit ChineseInvestors.com

Subscribe and watch our video commentaries: https://www.youtube.com/user/Chinesefncom

Follow us on Twitter for real-time Company updates: https://twitter.com/ChineseFNEnglsh

Like us on Facebook to receive live feeds: https://www.facebook.com/Chinesefncom;

https://www.facebook.com/Chineseinvestors.com.english

Add us on WeChat: Chinesefn or download iPhone iOS App: Chinesefn.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Contact:
ChineseInvestors.com, Inc.
227 W. Valley Blvd, #208 A
San Gabriel, CA 91776

Investor Relations:
Alan Klitenic
+1-214-636-2548

Corporate Communications:
NetworkNewsWire (NNW)
New York, New York
http://www.NetworkNewsWire.com
+1-212-418-1217 Office
Editor@NetworkNewsWire.com

$NETE Free Research Report from WallStEquities

LONDON, UK / June 5, 2018 / If you want a free Stock Review on SNAP sign up now at www.wallstequities.com/registration. On Monday, June 04, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Seven out of nine sectors ended Monday’s trading session in bullish territories. Taking into consideration yesterday’s market sentiment, WallStEquities.com assessed the following Internet Software & Services equities this morning: Net Element Inc. (NASDAQ: NETE), SINA Corp. (NASDAQ: SINA), Snap Inc. (NYSE: SNAP), and Square Inc. (NYSE: SQ). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Net Element

On Monday, shares in North Miami Beach, Florida headquartered Net Element Inc. recorded a trading volume of 164,354 shares. The stock ended at $6.85, declining 2.84% from the last trading session. The Company’s shares have gained 29.98% over the previous three months. The stock is trading below its 50-day moving average by 13.19%. Furthermore, shares of Net Element, which operates as a financial technology and value-added solutions company worldwide, have a Relative Strength Index (RSI) of 35.66. Get the full research report on NETE for free by clicking below at:

www.wallstequities.com/registration/?symbol=NETE

SINA Corp.

Beijing, China headquartered SINA Corp.’s stock finished yesterday’s session 1.18% higher at $93.33. A total volume of 943,949 shares was traded. The Company’s shares have gained 4.81% in the last twelve months. The stock is trading below its 50-day moving average by 2.41%. Furthermore, shares of SINA, which through its subsidiaries, operates as an online media company in China, have an RSI of 52.06. Today’s complimentary research report on SINA is accessible at:

www.wallstequities.com/registration/?symbol=SINA

Snap Inc.

At the close of trading on Monday, shares in Venice, California headquartered Snap Inc. saw a rise of 5.93%, ending the day at $12.32. The stock recorded a trading volume of 50.56 million shares, which was higher than its three months average volume of 25.15 million shares. The Company’s shares have advanced 12.31% in the last month. The stock is trading below its 50-day moving average by 6.43%. Moreover, shares of Snap, which operates as a camera company in the US and internationally, have an RSI of 60.41.

On May 21st, 2018, research firm MoffettNathanson upgraded the Company’s stock rating from ‘Sell’ to ‘Neutral’. Sign up for free on Wall St. Equities and claim the latest report on SNAP at:

www.wallstequities.com/registration/?symbol=SNAP

Square

San Francisco, California headquartered Square Inc.’s shares ended the day 3.01% higher at $61.62 with a total trading volume of 10.70 million shares. The stock has gained 24.36% in the last month, 21.38% in the previous three months, and 163.79% over the last twelve months. The Company’s shares are trading above their 50-day and 200-day moving averages by 19.32% and 48.94%, respectively. Additionally, shares of Square, which provides payment and point-of-sale solutions in the US and internationally, have an RSI of 74.62.

On June 01st, 2018, research firm Needham reiterated its ‘Buy’ rating on the Company’s stock with an increase of the target price from $55 a share to $65 a share. See the free research coverage on SQ at:

www.wallstequities.com/registration/?symbol=SQ

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

$ETST Attends Biggest, Sponsors 3 Cannabis Expos in Canada

DORAL, Florida, June 05, 2018 — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, as well as research and development, offers a report on the company’s presence at four recent cannabis expos held in Canada and the United States. Over the past three weeks, Earth Science Tech attended the Toronto Lift & Co. Expo, sponsored and attended the CannXperience and Florida Medical Cannabis Conference & Exhibition, and sponsored the Cannabis World Congress & Business Expo.

Industry Day and Expo at the Lift and Co. Expo
The two Lift and Co. Expos  in Toronto and Vancouver  are the premier events for anyone involved in the Canadian cannabis industry, making it a perfect place for the ETST team to appear. Dr. Michel Aubé , the Company’s CEO & CSO, attended the event, networking with key individuals.

“I met many leaders in the Canadian medical cannabis industry, as well as future leaders in the burgeoning legal recreational cannabis industry and  visionary lenders who are active in financing cannabis industry growth,” Aubé said. “We will pursue some of these new relationships in the coming months.”

CannXperience and Florida Medical Cannabis Conference & Exhibition
Both CannXperience and Florida Medical Cannabis Conference – held in Fort Lauderdale  and Sarasota – involved Florida’s medical cannabis industry. ETST’ss COO Gagan Hunter attended both events, handing out samples and marketing material at a company-sponsored booth while representing the brand in his 15-minute speech presentation. The Company also helped sponsor the event, providing the ETST logo and Company information with event marketing material distributed throughout the event.

“Both events were very effective in spreading brand awareness, learning more about the industry, and networking,” Hunter said. “I got a lot of positive feedback on our brand and connected with many doctors, potential investors, and potential synergistic companies.”

Cannabis World Congress & Business Expo
The Cannabis World Congress & Business Expo  in New York is a national level cannabis event which the Company sponsored to spread brand awareness.. The Company’s President and Director, Nickolas S. Tabraue, attended the event, learning from other companies and networking with individuals.

“Thanks to our passionate and like-minded team, we are now able to participate in beneficial cannabis industry events to spread awareness and network,” Tabraue said.. “A lot was achieved by sponsoring and attending the four events during the past three weeks, leaving a strong footprint in the cannabis industry. We look forward on attending more events to come and sharing many exciting updates very soon.”

About Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, and studies through DV Biologics prove it lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets, and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market.
To learn more, please visit: www.EarthScienceTech.com

ETST currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

Earth Science Pharmaceutical
Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharma, Inc. (“ESP”) is committed to the development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. ESP’s CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. ESP is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
To learn more please visit: www.EarthSciencePharmaceutical.com

Cannabis Therapeutics
Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds three provisional application patents for a CBD product that is focused on developing treatments for breast and ovarian cancers, as well as two generic CBD based pharmaceutical drugs.
To learn more please visit: www.CannabisThera.com  

KannaBidioiD
KannaBidioid, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioiD, Inc. (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
To learn more please visit: www.KannaBidioiDInc.com

Earth Science Foundation, Inc.
Earth Science Foundation, Inc., is awholly owned subsidiary of Earth Science Tech, Inc. (ETST). Earth Science Foundation, Inc. (“ESF”) is in the process of becoming a non-profit organization to accept grants and donations to conduct further studies and help donate Earth Science Tech, Inc.’s effective CBD products to those in need.
To learn more please visit: www.ETSTFoundtion.org

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact:
Dave Demarest 
305.546.7640 Office

Company Contact:
www.EarthScienceTech.com  
Nickolas S. Tabraue
President & Director
305.615.2118

$NETE JGR Capital Highlights Growth in Q1 2018, Events Industry Traction

• Independent research firm JGR Capital predicts more growth for Net Element in North American and emerging markets
• Research note also highlights company’s focus on the development of blockchain-based technology
• Via Unified Payments subsidiary, vendors at any event will be able to use mobile point-of-sale tools and self-order kiosks to accept multi-channel payments

Global financial technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) is set for sustained organic growth through its North American transaction solutions segment. Following the release of its first quarter 2018 financial results, which included a 17.8 percent year-over-year revenue increase, independent equity research firm JGR Capital issued an updated research note on May 21 (http://nnw.fm/xh27A). The note mentioned Net Element’s Q1 2018 financial results, which indicated total revenue of $15.98 million, compared to $13.6 million in Q1 2017. It also remarked on how the same first quarter financials show that Net Element managed to cut its selling, general and administrative expenses by over $380,000.

Additionally, the research note made mention of the company’s expansion into international markets, with JGR Capital’s analysts expecting the Russian market to add to Net Element’s international revenues this year. The report attributed Net Element’s strong growth in North America to the success of its Aptito system, a payment service developed for the restaurant sector. Aptito’s cloud-based payment solution allows restaurants to integrate a point of sale solution with digital menus, self-order kiosks and kitchen displays.

Another major point noted by JGR Capital was the company’s focus on the development of blockchain-based technology with the launch of its proprietary Netevia platform, which offers same-day funding to eligible merchants, easy merchant account set up and integration, payment conversion optimization, competitive pricing for payment acceptance services and other advantages and features.

The JGR Capital update came two days before Net Element announced the launch of a payment solution tailor-made for the needs of the multibillion-dollar events industry (http://nnw.fm/O1X2f). Via subsidiary Unified Payments, events industry vendors will be able to use mobile point-of-sale systems and self-order kiosks, as well as benefit from chargeback protection and acceptance of multi-channel payments. Unified Payments’ solutions will be fully integrated with vendors’ existing payment systems, allowing seamless transactions

In a news release, Vlad Sadovskiy, Net Element’s president of integrated payments, said, “We are excited to provide the event management industry with fully integrated, feature rich payment acceptance solutions. Our capabilities have the potential to dramatically change the way event transactions are processed today.”

Vendors will have access to programs such as ‘Fast Pass Funding’, which allows same-day funding; ‘Complimentary Equipment Placement Program’, which offers access to free payments equipment rental and on-site tech support; and ‘Zero Pay’, a cash discount program which will allow vendors to pocket 100 percent of their sales revenue.

The move will allow Net Element to tap into a highly prolific market, which generates more than $330 billion in direct spending and over $845 billion in business sales each year while supporting 5.9 million jobs across the United States (http://nnw.fm/S0cM9).

For more information, visit the company’s website at www.NetElement.com

More from NetworkNewsWire

• Crexendo, Inc. (CXDO) Starts Presentation at the 8th Annual LD Micro Invitational
• SG Blocks, Inc. (SGBX) Starts Presentation at the 8th Annual LD Micro Invitational
• InMed Pharmaceuticals Inc. (TSX: IN) (OTCQX: IMLFF) Starts Presentation at the 8th Annual LD Micro Invitational

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$FRSX Completes Successful Trial of Cellular-Based Eye-Net™

Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX), an innovator in automotive vision systems and V2X (vehicle to everything) cellular-based solutions, announced today, in collaboration with the city of Ashdod and NoTraffic Ltd., that is has successfully completed a controlled trial of its Eye-Net™ accident prevention solution. Eye-Net™ is a V2X cellular-based accident prevention solution, designed to provide pre-collision alerts in real time to pedestrians and vehicles by using smartphones and relying on existing cellular networks.

The trial was conducted at a central intersection in Ashdod, a city in the center of Israel, and was carried out in collaboration with NoTraffic Ltd., which develops traffic management systems for cities based on a network of sensors deployed at intersections with traffic lights. Supervision was provided by BWR (Blue and White Robotics) as part of the Ashdod Smart Mobility Living Lab project, and the trial was carried out with the support of the Ministry of Transport and the Ayalon Highway company as part of the national plan to promote smart transportation. The purpose of the trial was to integrate innovative technologies designed for smart cities, while creating a reliable communication channel between road users and smart infrastructure. During the trial, Foresight tested its Eye-Net™ system in various scenarios and integrated it with the NoTraffic smart system installed at the intersection.

In the first part of the trial, several accident-simulated scenarios including vehicles and/or a pedestrian were performed. In all cases, the parties were using the Eye-Net™ application installed on their cellular phones and received real-time alerts in order to prevent a collision. The second part of the trial tested the integration of the Eye-Net™ system with NoTraffic’s smart infrastructure system in accident-simulated scenarios where only one of the vehicles involved was connected to the Eye-Net™ system. NoTraffic’s system, which was installed at the intersection, identified the non-connected driver or pedestrian using a smart sensor, and transmitted the information to the driver using the Eye-Net™ system, in order to prevent a collision.

In all scenarios, Foresight met all the pre-defined objectives and indicators for the real-time use of the Eye-Net™ system in a manner that enabled all road users to brake safely and on time. During the trial, the information was streamed in real time to the control center onsite and displayed the location and time of occurrence of the simulated collisions on a map, as well as the classification of the road users involved.

“We were pleased to have the opportunity to introduce our company’s innovative system and collaborate with NoTraffic and the Ashdod Municipality, which, like Foresight, are entities that promote innovation and the use of advanced technologies in the field of accident prevention,” said Haim Siboni, CEO of Foresight. “This collaboration enabled us to test our ability to integrate with smart infrastructure in order to reduce the number of accidents in an urban environment. Integration with the NoTraffic system enabled Foresight to examine a variety of realistic scenarios, all of which presented impressive results. We intend to continue the development process in order to achieve extensive exposure for our company’s unique, life-saving technology.”

“The city of Ashdod, led by Dr. Yechiel Lasry, continues to promote the concept of smart transportation in order to improve the safety of the city’s residents,” said Dr. Smadar Itzkovich, Head of Industrial Development & Ashdod Smart Mobility Living Lab. “The trial was first of its kind and demonstrated how ‘smart’ communication between vehicles, pedestrians and traffic lights can identify and alert all road users of an upcoming collision. The trial results proved that the number of accidents can be significantly reduced. This is another step for the Ashdod Smart Mobility Living Lab in promoting smart transportation at the national and international levels.”

“We are glad to have the privilege to cooperate with Foresight and the Ashdod Municipality – two entities that are making every effort to promote smart transportation in Israel and abroad,” said Tal Kreisler, CEO of NoTraffic. “The trial was a breakthrough in the field of smart transportation and presents, for the first time, collaboration between infrastructure and road users in order to make the world a safer place where accidents are not commonplace. This is a significant milestone that sets the basis for preparing the roads for a connected and autonomous world by using advanced technology that can be deployed today. The scenarios demonstrated in the trial are based on recent fatal accidents of connected and autonomous vehicles that could be avoided in the future using the unique technology developed by NoTraffic.”

Foresight recently announced that it signed an agreement with Tamda Ltd. (TASE: TMDA) in order to merge its Eye-Net™-related activities into Tamda.

For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, please visit www.foresightauto.com, follow @ForesightAuto on Twitter, or join Foresight Automotive on LinkedIn.

About Foresight

Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX), founded in 2015, is a technology company engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry. Foresight’s vision systems are based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company, through its wholly owned subsidiary Foresight Automotive Ltd., develops advanced systems for accident prevention which are designed to provide real-time information about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. The company’s systems are targeting the Advanced Driver Assistance Systems (ADAS), semi-autonomous and autonomous vehicle markets. The company estimates that its systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform and advanced technology.

About Ashdod Municipality and Ashdod Smart Mobility Living Lab Project

In recent years, the city of Ashdod has been promoting the Ashdod Smart Mobility Living Lab, in cooperation with MIT, which focuses on the use of urban space for the implementation of advanced technologies for smart and autonomous transportation. The purpose of the project is primarily to increase road safety and to encourage the use of public and cooperative transportation. In addition, a technological and legal infrastructure was established to promote cooperation with academic institutions and technological companies such as Mobileye, Microsoft, ITURAN, etc.

About NoTraffic

NoTraffic Ltd. develops a traffic management platform that optimizes traffic lights in real-time based on smart sensors, and prepares the road infrastructure for the connected and autonomous era. The platform is powered by integrating data from proprietary computer vision algorithms and data collected through vehicle-to-infrastructure (V2I) communication

Advanced artificial intelligence (AI) algorithms identify and track all road users, including pedestrians, and optimize the traffic signals while considering nearby intersection traffic. The system enables cities to implement their traffic policy in a seamless way and operates autonomously in order to maximize traffic flow, reduce congestion, prioritize different types of vehicles, and prevent accidents. www.notraffic.tech

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Foresight is using forward-looking statements in this press release when it discusses that it intends to continue the development process in order to achieve extensive exposure for the company’s unique, life-saving technology, and the closing of the merger agreement with Tamda, if at all. Because such statements deal with future events and are based on Foresight’s current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of Foresight could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Foresight’s annual report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on March 27, 2018, and in any subsequent filings with the SEC. Except as otherwise required by law, Foresight undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Foresight is not responsible for the contents of third party websites.

Investor Relations:
MS-IR
Miri Segal-Scharia, 917-607-8654
msegal@ms-ir.com
or
Corporate Communications:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212-418-1217 Office
Editor@NetworkNewsWire.com

$DJACF Highlighted in BLOCKStrain Technology $DNAX Article on Big Data and Cannabis

• Blockchain-based genetic registration process provides verification security for growers and consumers alike
• Global cannabis market projected to reach $31.4 billion by 2021
• WeedMD becomes first Canadian Licensed Producer to adopt BLOCKStrain’s technology

As the legal cannabis market continues to develop, concerns about ensuring transparency and quality control for the growing number of medicinal and recreational drug products sold to consumers continue to drive a necessary breed of entrepreneurship required to legitimize the industry. BLOCKStrain Technology Corp. (TSX.V: DNAX) has emerged as an innovative leader in the quality control arena, releasing its proprietary supply chain management platform as a secure means of providing confidence in the inventory pipeline while safeguarding the interests of licensed growers.

Blockchain’s ability to provide an inalterable and transparent multi-user platform for tracing manufacture-to-market transactions within virtually any industry has gained an exuberant following among investors during recent months, sparking sometimes-explosive growth in entities’ values.

BLOCKStrain has adapted the open-source ledger’s technology to provide a cannabis genome-to-sale genetic chain of evidence that provides proof of ownership to brand builders in the multibillion-dollar industry and allows consumers to verify where a product originated and where it has been before landing in their shopping carts. In between the two extremes of the pipeline, distributors, shipping companies and government agencies also have a stake in auditing a product’s wellbeing. Moreover, the platform forms the foundation for what could become IP protection for growers and producers who produce branded products.

WeedMD Inc. (TSX.V: WMD) (OTC: WDDMF) (FSE: 4WE), which recently announced a merger with Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF), in May became the first Canadian Licensed Producer (LP) to adopt the BLOCKStrain platform for gene record-keeping purposes. As Canada and select U.S. states continue pushing toward full national legalization of cannabis as a recreational drug as well as a medicinal product, the BLOCKStrain platform ensures competitive advantage for their products at retail by giving consumers more transparent data on each product.

“Unique and differentiated strains and product offerings have always been, and will remain, a cornerstone of WeedMD’s business model. Validating and protecting that intellectual property through BLOCKStrain’s platform will prove invaluable as we scale operations and broaden our distribution throughout the country as well as internationally,” WeedMD Chief Financial Officer Keith Merker said about the agreement (http://cnw.fm/VAxF4).

Cannabis presents an interesting challenge to players in the industry. Increasingly in demand for its reputed healing properties as well as for a burgeoning social drug movement, the plant contains more than 500 known chemical compounds that are, in some cases, pharmacologically active and the basis of worldwide marijuana restrictions. With cannabis, consumers have a keen interest in being able to identify what they are purchasing at a genetic level, and blockchain provides the potential to build up a new breed of custom retail.

Government agencies also have a public stake in ensuring the production quality, product potency and measurable equivalency standards of cannabis derivatives claiming a medicinal or wellness benefit. BLOCKStrain helps provide the supply chain data to support a regulatory framework that achieves this goal.

Thousands of cannabis strains exist, and, as new breeding takes place, craft growers also have an interest in protecting their intellectual property. For growers, the BLOCKStrain platform provides a gene-registration defense of intellectual property rights and establishes a historical proof of ownership standard that may sustain challenges in the legal arena (http://cnw.fm/P9pGw). Once growers create an account with BLOCKStrain, they can deliver seeds, flower and derivative products that will be tested at an approved facility to provide identifying data. BLOCKStrain administrators also provide a verification process for pre-existing cannabis strain genetic data that can become part of a client’s profile.

Closing the consumer supply loop, users can also use BLOCKStrain to rate products and share their opinions, which become part of the strain’s immutable record.

“We have a mission to take an industry that was originated in the shadows and, using the power of big data and a blockchain-supported supply chain management model, bring it into the light,” stated BLOCKStrain CEO Robert Galarza. “The business opportunity is massive.”

For more information, visit the company’s website at www.BLOCKStrain.io

More from CannabisNewsWire

• EVIO Inc. (EVIO) Expands Footprint to Los Angeles
• Marijuana Company of America, Inc. (MCOA) Announces Hiring of Field Manager, Facility Secured for New Brunswick Hemp Project
• NUGL Inc. (NUGL) is “One to Watch”

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

$DNAX Leverages #BigData to Secure #Cannabis Pipeline

• Blockchain-based genetic registration process provides verification security for growers and consumers alike
• Global cannabis market projected to reach $31.4 billion by 2021
• WeedMD becomes first Canadian Licensed Producer to adopt BLOCKStrain’s technology

As the legal cannabis market continues to develop, concerns about ensuring transparency and quality control for the growing number of medicinal and recreational drug products sold to consumers continue to drive a necessary breed of entrepreneurship required to legitimize the industry. BLOCKStrain Technology Corp. (TSX.V: DNAX) has emerged as an innovative leader in the quality control arena, releasing its proprietary supply chain management platform as a secure means of providing confidence in the inventory pipeline while safeguarding the interests of licensed growers.

Blockchain’s ability to provide an inalterable and transparent multi-user platform for tracing manufacture-to-market transactions within virtually any industry has gained an exuberant following among investors during recent months, sparking sometimes-explosive growth in entities’ values.

BLOCKStrain has adapted the open-source ledger’s technology to provide a cannabis genome-to-sale genetic chain of evidence that provides proof of ownership to brand builders in the multibillion-dollar industry and allows consumers to verify where a product originated and where it has been before landing in their shopping carts. In between the two extremes of the pipeline, distributors, shipping companies and government agencies also have a stake in auditing a product’s wellbeing. Moreover, the platform forms the foundation for what could become IP protection for growers and producers who produce branded products.

WeedMD Inc. (TSX.V: WMD) (OTC: WDDMF) (FSE: 4WE), which recently announced a merger with Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF), in May became the first Canadian Licensed Producer (LP) to adopt the BLOCKStrain platform for gene record-keeping purposes. As Canada and select U.S. states continue pushing toward full national legalization of cannabis as a recreational drug as well as a medicinal product, the BLOCKStrain platform ensures competitive advantage for their products at retail by giving consumers more transparent data on each product.

“Unique and differentiated strains and product offerings have always been, and will remain, a cornerstone of WeedMD’s business model. Validating and protecting that intellectual property through BLOCKStrain’s platform will prove invaluable as we scale operations and broaden our distribution throughout the country as well as internationally,” WeedMD Chief Financial Officer Keith Merker said about the agreement (http://cnw.fm/VAxF4).

Cannabis presents an interesting challenge to players in the industry. Increasingly in demand for its reputed healing properties as well as for a burgeoning social drug movement, the plant contains more than 500 known chemical compounds that are, in some cases, pharmacologically active and the basis of worldwide marijuana restrictions. With cannabis, consumers have a keen interest in being able to identify what they are purchasing at a genetic level, and blockchain provides the potential to build up a new breed of custom retail.

Government agencies also have a public stake in ensuring the production quality, product potency and measurable equivalency standards of cannabis derivatives claiming a medicinal or wellness benefit. BLOCKStrain helps provide the supply chain data to support a regulatory framework that achieves this goal.

Thousands of cannabis strains exist, and, as new breeding takes place, craft growers also have an interest in protecting their intellectual property. For growers, the BLOCKStrain platform provides a gene-registration defense of intellectual property rights and establishes a historical proof of ownership standard that may sustain challenges in the legal arena (http://cnw.fm/P9pGw). Once growers create an account with BLOCKStrain, they can deliver seeds, flower and derivative products that will be tested at an approved facility to provide identifying data. BLOCKStrain administrators also provide a verification process for pre-existing cannabis strain genetic data that can become part of a client’s profile.

Closing the consumer supply loop, users can also use BLOCKStrain to rate products and share their opinions, which become part of the strain’s immutable record.

“We have a mission to take an industry that was originated in the shadows and, using the power of big data and a blockchain-supported supply chain management model, bring it into the light,” stated BLOCKStrain CEO Robert Galarza. “The business opportunity is massive.”

For more information, visit the company’s website at www.BLOCKStrain.io

More from CannabisNewsWire

• EVIO Inc. (EVIO) Expands Footprint to Los Angeles
• Marijuana Company of America, Inc. (MCOA) Announces Hiring of Field Manager, Facility Secured for New Brunswick Hemp Project
• NUGL Inc. (NUGL) is “One to Watch”

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

$PBIO Boosts Drug Development Process through Acquisition of PreEMT Platform

• Biologics offer novel ways of treating degenerative diseases like Alzheimer’s
• Biologics are one of the fastest-growing drug categories
• PreEMT™ technology improves quality, reduces cost of biologic manufacture

When we think of drugs, an image of potions in round-bottom flasks conjured up in labs comes to mind, or perhaps pills of one sort or another ingested with a sip of water, for about 90 percent of drugs currently in use have that profile. However, discovering that the human body will act as its own physician by dispensing protective proteins called antibodies to fight the toxins that bring on diseases has spurred efforts, naturally enough, to develop those proteins synthetically. This new class of biotherapeutic protein drugs, or biologics, tends to be more effective at combating pathological conditions with less side effects, since they mimic endogenously produced proteins, which target highly specific parts of the invader (antigens). Unfortunately, the production of biologics is easier said than done; it typically requires hundreds of process steps to assemble one of these complex biotherapeutic proteins. Therefore, it should come as no surprise that the PreEMT™ platform recently acquired by Pressure BioSciences Inc. (OTCQB: PBIO) is a welcome addition to biologic development.

The company recently announced the signing of an agreement with an international biopharmaceutical company to assess the potential of the PreEMT™ technology as the basis for a unique manufacturing process and as an enhancement to the quality of a key protein-based drug currently under development (http://nnw.fm/Yr5lG).

Many currently available drugs are synthesized chemically, with molecular structures that are “well defined and relatively simple” (http://nnw.fm/abUv6). Their simplicity makes them easy to produce and easy for the human body to assimilate. A good example is acetylsalicylic acid (ASA), the active ingredient in aspirin, which has a molecular weight of about 180 grams per mole. Generally, such drugs are swallowed in pill or liquid form before entering the gastrointestinal system and blood stream by diffusion through the intestinal wall. Once in the blood, they have access to the entire body, their tiny size allowing them to penetrate cell membranes easily.

Biologics, by contrast, are much larger compounds that mimic the complex endogenous proteins produced by the immune system. They are generally composed of hundreds of amino acids and may carry a weight as high as 150,000 grams per mole. Biologics will bind to the specific cell receptors associated with a particular disease. For example, monoclonal antibodies are adept at recognizing very specific structures on the surface of cells. This specificity means that healthy cells are not adversely affected, resulting in less side effects. This is one reason that treatment by biologics can be superior to regimens developed with traditional combinatorial chemistries.

Because of their complexity, the manufacture of biotherapeutic proteins is prone to errors, very often falling prey to aggregation and misfolding. Misfolding occurs when the normal, three-dimensional structure of a protein becomes distorted, which may lead the protein to aggregate, a result that is quite the opposite of the benign outcomes intended in the manufacture of biologics. Many pathological conditions occur naturally by misfolded proteins. The list includes Alzheimer’s disease, which affects about 10 percent of the adult population over 65 years old in North America, as well as Parkinson’s disease and Huntington’s disease. However, PBIO’s PreEMT patented technology could reduce the incidence of misfolding in manufacture.

“PreEMT results in the dissolution of protein aggregates, which may have a significant impact on the quality of protein drugs by improving protein activity, homogeneity, and stability, as well as by reducing undesirable immunogenic properties”, Dr. Alexander Lazarev, PBIO’s vice president of R&D, stated in a news release.

Richard T. Schumacher, president and CEO of PBIO, added “Importantly, should the PreEMT technology result in more efficient production of high quality protein-based therapeutics for any biopharmaceutical company developing new protein-based therapeutics, manufacturing-scale licenses have the potential to generate millions of dollars in annual royalty revenue for PBIO.”

The technology is likely to find application across a wide range of proteins in reducing aggregation levels in bulk or final formulations, thereby improving product safety. PreEMT is scalable, and it is expected to significantly reduce manufacturing costs.

The acquisition of the PreEMT technology gives PBIO a footprint in the very large and growing biologics contract research services sector. The company is also busily developing its recently patented Ultra Shear Technology (UST) platform. The scalable, pressure-based UST technology creates stable nanoemulsions of otherwise immiscible fluids. It can be used to extend the shelf life of homogenized dairy products without refrigeration, for example. All the while, PBIO continues its focus on its core product line that generated $2.2 million in 2017 revenue: the development of pressure cycling technology (PCT)-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications.

For more information, visit the company’s website at www.PressureBioSciences.com

More from NetworkNewsWire

• Sharing Services, Inc.’s (SHRV) ‘Elevacity’ Division Taps into Wellness, the Largest Direct Sales Classification in the US and Globally
• TMSR Holding Company Ltd. (NASDAQ: TMSR) is “One to Watch”
• Virtual Crypto Technologies Inc. (VRCP) Leads Breakthrough in Cryptocurrency ATMs, Enabling Rapid Crypto-to-Cash Transactions

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$CIIX Focuses on Financial Consulting

• Focusing on the initial vision of financial consulting to the Chinese-speaking community
• Recent developments in CIIX’s cryptocurrency media and educational services, cryptocurrency ATMs and cryptocurrency mining shared at MicroCap Conference
• Committed to continued real-time education regarding use of cryptocurrency

ChineseInvestors.com, Inc. (OTCQB: CIIX) provides real-time market commentary, analysis and education-related services to the Chinese-speaking community. “The company endeavors to be on the cutting edge of blockchain technology and to stay ahead of the curve in an effort to continue to build shareholder value and increase revenues this year,” CEO Warren Wang stated in a news release (http://cnw.fm/J0kLL). As the company spins off its hemp assets into a private company, it is refocusing on its initial vision of financial consulting. The company seeks to explore new ways of expansion within its core financial services. This move allows CIIX to focus on brand building, financial marketing and a recent move into the cryptocurrency and blockchain technology industry.

This past week, Wang presented at the MicroCap Conference in New York City. Micro- and small-cap attendees were presented information into CIIX’s developments in cryptocurrency business. Recent developments within the company were shared, including its developing cryptocurrency business focusing on cryptocurrency media and educational services, cryptocurrency ATMs and cryptocurrency mining.

The focus on educating CIIX’s global Chinese-speaking audience is evident on its crypto news website, www.NewCoins168.com, and through its daily video broadcast, ‘Bitcoin MultiMillionaire’, reporting on cryptocurrency news from the floor of the NYSE. These platforms only strengthen the company’s focus on being a leader in financial information. The company continues to be on the cutting edge of technology, with the use of a Bitcoin ATM in the lobby of its San Gabriel, California, headquarters providing instruction in both Chinese and English.

CIIX is also investigating ventures into cryptocurrency mining following its recent purchase of application specific integrated circuit (“ASIC”) machines that mine for cryptocurrencies, such as bitcoin and Litecoin. Initial reports suggest this will be a successful venture, and CIIX is considering the purchase of 500 or more additional ASIC units plus other equipment for blockchain mining.

For more information, visit the company’s website at www.ChineseInvestors.com

More from CannabisNewsWire

• Marijuana Company of America, Inc. (MCOA) Announces Hiring of Field Manager, Facility Secured for New Brunswick Hemp Project
• NUGL Inc. (NUGL) is “One to Watch”
• ChineseInvestors.com, Inc. (CIIX) Subsidiary Expands Sales Force to Grow Division’s Domestic Revenues

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

$TMSR Common Stock Continues to Trade Following Nasdaq Hearings Panel Decision

$NETE Enables Sales Transactions through Broad Range of Platforms

• Retail e-commerce sales expected to reach $4.88 trillion by 2021
• Net Element enables expanding scope of face-to-face and e-commerce transactions
• Company building additional transaction capabilities through blockchain project

In a world with rapidly expanding opportunities for commerce at a truly worldwide scale, one of the greatest challenges businesses face is staying abreast of the technologies that keep people linked together across the globe. Net Element, Inc. (NASDAQ: NETE) is in the business of making business happen, ensuring that sales transactions can take place across a wide array of potential platforms, globally or in-person right at a merchant’s store.

Not so far from the historical era of bartering for goods and services and yet light years ahead in terms of mobility, modern businesses and consumers are increasingly accustomed to moving merchandise without a ‘show-me-the-money’ mentality. Payment cards, emailed and texted statements and short-range electronic broadcasting all serve to verify in a confident and practically instantaneous manner that a resource of funds sufficient to cover a debt exists somewhere in the world and can be made available to another specified location somewhere in the world.

Through its brands, Net Element specializes in linking consumer mobile phones, banks, unbanked online distribution outlets and offline brick-and-mortar storefronts, providing value-added services and business analytics.  The goal is to help companies assess their competition, evaluate their own productivity and get to know their clients’ preferences in the U.S. and emerging markets around the globe.

The company’s North America Transactions Solutions business segment recorded year-over-year revenue growth of 21 percent in 2017 with a history of 28 percent growth, driven mostly by its successes with its Unified Payments subsidiary (http://nnw.fm/zV1H8). Unified Payments’ Fast Pass Funding service gives eligible merchants access to revenues in as little as three hours during regular business days, improving turnaround time for transaction processing to same-day significance.

Entry into the Enterprise Ethereum Alliance has bolstered the company’s development of secure blockchain protocols to enhance its transaction solutions, including its new Netevia multi-channel payments platform that offers end-to-end processing through easy-to-use APIs. The company’s other subsidiaries — international small content mobile solution entity Digital Provider, cloud-based point-of-sale wireless tech platform Aptito, and processor agnostic e-commerce manager PayOnline — enhance its gravitas in the industry.

Independent equity research firm JGR Capital announced in April that it had launched its small cap data coverage of Net Element as a service to investors and shareholders (http://nnw.fm/M2ieN), providing additional attention to the company’s capabilities. In January, Net Element wrapped up a $7.55 million restricted common stock and warrant private placement with an institutional investor than brought in additional funding for its blockchain initiatives.

“The Company’s balance sheet is now the strongest in its history, allowing Net Element to support future growth opportunities,” Net Element CEO Oleg Firer stated in a news release.

Cumulative data from market analyst Statista projects that retail e-commerce sales worldwide will continue to grow at a marked pace, doubling revenues to $4.88 trillion by 2021. The analysis reports that online shopping is one of the most popular online activities worldwide, but the usage varies by region. In 2016, an estimated 19 percent of all retail sales in China occurred via internet, but, in Japan, the share was only 6.7 percent. Desktop PCs are still the most popular device for placing online shopping orders, but mobile devices, especially smartphones, are catching up, the report states (http://nnw.fm/sy5E3).

For more information, visit the company’s website at www.NetElement.com

More from NetworkNewsWire

• Sharing Services, Inc.’s (SHRV) ‘Elevacity’ Division Taps into Wellness, the Largest Direct Sales Classification in the US and Globally
• TMSR Holding Company Ltd. (NASDAQ: TMSR) is “One to Watch”
• Virtual Crypto Technologies Inc. (VRCP) Leads Breakthrough in Cryptocurrency ATMs, Enabling Rapid Crypto-to-Cash Transactions

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$PVOTF Signs Option Agreement to Acquire Licensing Rights to TriVair™

VANCOUVER, May 31, 2018 – Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) (“Pivot” or the “Company”) is pleased to announce that the Company has signed an Option Agreement with IP Med Inc., based in Oceanside, New York, to acquire an exclusive worldwide license for Trivair™ Nasal and Pulmonary Breath-Propelled Drug Delivery Systems™ for the delivery of Pivot’s Ready-To-Infuse-Cannabis (“RTIC”) cannabinoid products. The Option expires in 6-months during which time Pivot will determine compatibility with Pivot’s RTIC powder formulations. Upon successful completion of the evaluation Pivot will have the Option to enter into a Definitive Licensing Agreement with IP Med for the TriVair™ device.

Winner of the Frost and Sullivan 2009 European Drug Delivery Product Differentiation Innovation of the Year Award, the intuitive and easy-to-use TriVair™ patented devices are discreet and disposable, deliver pre-loaded precise unit doses and eliminate the risk of microbial contamination. Clinical studies using the TriVair™ Delivery System have demonstrated that the powder compound is widely distributed in all areas of the nasal cavity (with no area of powder accumulation), is effective in retaining medication in the nasal cavity without pharyngeal penetration and showed a high degree of patient acceptability.

The TriVair™ Nasal device uses the body’s natural breath to propel a medication deep into the nasal cavity to targeted sites, bypassing the Blood Brain Barrier, providing the potential to better treat central nervous system diseases such as migraines, epilepsy, insomnia, and post-operative pain, the latter of which is often remedied by opioids. The TriVair™ Pulmonary device enables specific dosing to the pulmonary airways, thereby targeting the lungs. Such targeting can be highly relevant in the treatment of respiratory diseases and in the prevention and treatment of respiratory infections.

Pivot will combine its patented RTIC™ cannabis powder technology with the TriVair™ delivery system to provide a rapid onset effect for patients and consumers in markets where regulations permit. Pivot’s Product Formulation Team, led by Dr. Leonid Lurya in Israel, has initiated testing to evaluate, modify and test formulations that achieve the desired particle size for delivery by the TriVair™ device.

IP Med’s Vice-President, Mr. Ben Isaacs, comments that “I am excited to partner with the team at Pivot Pharmaceuticals. With their product development and commercialization experience, and impressive RTIC powdered cannabis technology I am confident that the TriVair™ device will provide a safe and effective way for the delivery of cannabinoids into patients.”

Dr. Joseph Borovsky, Pivot’s Executive Vice President, Product Development, stated “We are very pleased to add the TriVair™ device to Pivot’s product line and expand the range of delivery systems for cannabinoids. This pre-loaded and single-use device, will be a disruptive technology and provide solutions for patients with special medical needs.”

Pivot’s Chief Medical Officer, Dr. Wolfgang Renz commented “Pivot continues to grow its portfolio of patented technologies specifically for the formulation and delivery of cannabinoids. We are very excited about the unique opportunity this differentiated product presents for patients seeking an alternative method to traditional cannabis practices. Upon the completion of our compatibility testing, Pivot will have the world’s first nasal and pulmonary powdered cannabis device for quick onset and use in the medical field. This combination product may be well suited for managing such indications as sleep disorder, migraine, late-stage cancer pain, and address opioid withdrawal.”

About IP Med Inc.

IP Med partners with (physician) inventors, academic institutions and pharmaceutical companies to bring their concepts to market: We create, develop (design and engineer), patent, prototype, build proof of concept, commercialize and/or monetize unique and innovative technologies and compounds in efficient and cost effective ways. IP Med’s founders bring 35 + years of success and experience in strategic planning and marketing for the pharmaceutical and medical product industries; working with top-tier companies including Pfizer, Wyeth, Eli Lilly, Merck, AstraZeneca and GlaxoSmithKline just to name a few. IP Med maintains close relationships with a vast network of executives within major companies in the medical arena; including pharmaceutical, biotech and medical device companies. For more information please visit www.ipmedinc.com

About Pivot Pharmaceuticals Inc.

Pivot Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Pivot’s wholly-owned medical cannabis products division, Pivot Green Stream Health Solutions Inc. (“PGS” or “Pivot Green Stream”), conducts research, development and commercialization of cannabinoid-based nutraceuticals and pharmaceuticals. Pivot’s wholly-owned U.S. subsidiary, Pivot Naturals, LLC, based in Costa Mesa, California, will manufacture and supply finished powderized cannabis products such as food additives, capsules, bulk powder and stick packs to the California market. PGS has acquired worldwide rights to “RTIC” Ready-To-Infuse Cannabis oil-to-powder technology, BiPhasix™ Dermal Drug Delivery platform technology (topical), Solmic Solubilisation technology (oral) and Thrudermic Transdermal Nanotechnology (transdermal) for the delivery and commercialization of cannabinoid, cannabidiol (CBD), and tetrahydrocannabinol (THC)-based products. For more information please visit www.PivotPharma.com

Cautionary Statement

Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as anticipate, believe, estimate, expect, intend, and similar expressions, as they relate to Pivot Pharmaceuticals Inc., Pivot Green Stream Health Solutions Inc., Pivot Naturals, LLC, IP Med Inc., or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, such as the failure to meet the conditions imposed by the CSE or other securities regulators, the level of business and consumer spending, the amount of sales of Pivot’s products, statements with respect to internal expectations, including with respect to the TriVair™ device, the competitive environment within the industry, the ability of Pivot to continue to expand its operations, the level of costs incurred in connection with Pivot’s expansion efforts, economic conditions in the industry, and the financial strength of Pivot’s customers and suppliers. Pivot does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.

$DJACF Files 2018 First Quarter Results

TORONTO, May 31, 2018 – Hiku Brands Company Ltd. (CSE: HIKU) (“Hiku” or the “Company”) is pleased to announce the filing of its financial statements and management discussion and analysis for the first quarter ended March 31, 2018. These filings are available for review on the Company’s SEDAR profile at www.sedar.com.

“The first quarter of 2018 was one that focused on solidifying our vertically integrated cannabis company and positioning us to win in the legal adult-use market in Canada.” said Alan Gertner, CEO of Hiku. “With our solid foundation of Tokyo Smoke and its existing retail footprint, our artisanal handcrafted cannabis grown at DOJA‘s state of the art facility in British Columbia, and our iconic brands like Van der Pop and Maïtri, we believe that Hiku is very well positioned to usher in the adult-use cannabis sector in Canada”.  Mr. Gertner added, “We are excited about our announced merger with WeedMD, a recognized leader in the medical cannabis sector. WeedMD brings considerable scalable production and seasoned R&D capabilities giving Hiku immediate access to cannabis flower, concentrates and innovative products that we believe will bolster our ability meet customers’ needs in the adult-use market.”

2018 Q1 Highlights

January

• Launched Hiku – The merger of DOJA Cannabis Company Limited and TS Brandco Holdings Inc. (“Tokyo Smoke”) closed and the combined company was renamed Hiku Brands Company Ltd. – becoming Canada’s first vertically integrated cannabis brand house and uniting the cannabis brands DOJA, Tokyo Smoke, and Van der Pop.

February

• Awarded Manitoba Retail License – 10006215 Manitoba Ltd. (“Tokyo Smoke Manitoba”), a company of which Hiku owns a 79.9% equity interest, with participation of BOBHQ, was conditionally awarded one of four master retail licenses in Manitoba’s Request for Proposal process for the opportunity to operate retail cannabis stores. The license gives Tokyo Smoke Manitoba the ability to operate legal retail cannabis stores and an online cannabis e-commerce platform in Manitoba.
• Entered into First International Partnership in Jamaica – Hiku entered into a letter of intent with Kaya Inc., the first licensed medical cannabis producer and dispensary operator in Jamaica, to launch a strategic alliance to pursue medical and adult-use cannabis branding, genetics, and retail opportunities in Jamaica and Canada.

March

• Announced Cannabis Oil Partnership – Signed a strategic partnership agreement with Vitalis Extraction Technology Inc., a Kelowna-based company at the forefront of CO2 extraction innovation.
• Bolstered Leadership Team – Made several key additions to the leadership team with significant expertise in retail, branding, government relations and communications.
• Redefining the Cannabis Retail Experience – Entered into an exclusive collaboration agreement with Jackman Reinvention Inc. (a strategic and creative brand consultancy with deep experience in retail execution) to create a blueprint for Hiku’s dispensary build-outs in select provinces.
• Bringing Exceptional Products to Market – Entered into a letter of intent to establish a co-marketing, retail and select distribution relationship with GSW Creative Corporation Inc., d/b/a dosist (“dosist”) (previously known as hmbldt), a leading wellness brand providing consistent, controlled and effective cannabis-based solutions.

Q2 2018 Highlights to Date

April

• Received Sales License – DOJA Cannabis Ltd. (“DOJA”), a wholly-owned subsidiary of Hiku, received an amendment to its sales license from Health Canada to include the sales of dried cannabis, cannabis plants and seeds.
• Hiku & WeedMD Merger – Hiku entered into a definitive agreement to merge with WeedMD Inc. (“WeedMD”), which would combine a premium cannabis brand house and retail focused operator in Hiku, with the significant production capabilities and differentiated medical brand in WeedMD (the “WeedMD Merger”). If the WeedMD Merger is completed, the combined company would have a diversified cannabis cultivation platform with four facilities from coast-to-coast with planned expansion capacity to potentially have the ability to produce over 56,000 kg by mid-2019.

May

• Acquired Quebec-Based Cannabis Brand Maïtri – The Company acquired 100% of the issued and outstanding shares of Maïtri Group Inc. (“Maïtri”), a Quebec-based cannabis accessory and design brand.
• De-levered the Company’s Balance Sheet – The Company offered the opportunity for eligible holders of 8% unsecured convertible debentures of Hiku due December 28, 2020 (the “Debentures”), whom in aggregate held $16,693,000 in principal, to elect to convert their Debentures during the period between May 17, 2018 and June 7, 2018 at the conversion price and in return receive an additional 250 common share purchase warrants (“Early Conversion Warrants”) of Hiku per $1,000 of principal amount of Debentures converted, in addition to the common shares of Hiku to be received in connection with such conversion. As at May 30, 2018, debentureholders owning $12,500,000 of outstanding Debentures elected to convert early and the Company now only has $4,193,000 in principal amount of Debentures outstanding.
• Newfoundland & Labrador Investment – The Company entered into a binding letter of intent (the “Oceanic LOI”) with Oceanic Releaf Inc. (“Oceanic”) and the sole shareholder of Oceanic. Oceanic is a Newfoundland & Labrador-based late-stage applicant under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). Under the terms of the Oceanic LOI, Hiku will invest up to $1,000,000 in cash and up to $2,000,000 worth of common shares of Hiku in exchange for 25% of the post-closing aggregate issued and outstanding shares of Oceanic on a fully-diluted basis (the “Oceanic Strategic Investment”). In connection with the Oceanic Strategic Investment and pursuant to the Oceanic LOI, Hiku and Oceanic intend to become licensed for cannabis retail locations within the province, and will enter into a retail agreement governing the operation of these stores. The Oceanic Strategic Investment is contingent upon securing retail licenses from the Government of Newfoundland & Labrador allowing Hiku to operate stores within the province.

About Hiku Brands

Hiku is focused on building a portfolio of engaging cannabis brands, unsurpassed retail experiences and handcrafted cannabis production. With a national retail footprint led by Tokyo Smoke, craft cannabis production through DOJA’s ACMPR licensed grow, and Van der Pop’s female-focused educational platforms, Hiku houses a portfolio that aims to set the bar for cannabis brands in Canada.

Hiku’s wholly-owned subsidiary, DOJA Cannabis Ltd., is a federally licensed to cultivate and sell cannabis pursuant to the ACMPR, owning two production facilities in the heart of British Columbia’s Okanagan Valley. Tokyo Smoke Manitoba, a company of which Hiku owns a 79.9% equity interest, has been conditionally awarded one of four master retail licenses in Manitoba. Hiku also operates a network of retail stores selling coffee, clothing and curated accessories, across British Columbia, Alberta and Ontario.

Forward-looking statements

This news release contains statements that constitute “forward-looking statements”. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Hiku’s actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects,” “plans”, “anticipates”, “believes”, “intends”, “estimates”, “projects”, “potential” and similar expressions, or that events or conditions “will”, “would”, “may”, “could” or “should” occur.

Forward-looking statements in this document include, among others, the Company’s expectations concerning the completion of the WeedMD Merger, the planned production capacity of the combined company, the arrival of the adult-use cannabis market, the Company’s planned operations in Manitoba, the Company’s strategic alliance with Kaya Inc. and any future operations in Jamaica, the build-outs of the Company’s facilities and future dispensaries (if any) and the completion of the Oceanic Strategic Investment (if at all) and the terms thereof. By their nature, forward-looking statements are based on the opinions and estimates of management at the date the information is made, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. Hiku is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

The Canadian Securities Exchange has not approved nor disapproved the contents of this news release.

SOURCE Hiku Brands Company Ltd.

View original content with multimedia: http://www.newswire.ca/en/releases/archive/May2018/31/c4435.html

Will Stewart, Vice President, Corporate Communications & Public Affairs, WStewart@Hiku.com, 416-899-9422Copyright CNW Group 2018

$ETST Eyes Future Uplisting to OTCQB Venture Market

• ETST issues new audio press release regarding its audits, Form 10, financing plans and fully reporting status
• ETST has started 2017 fiscal year audit, which is required, along with the approved Form 10, to uplist to the OTCQB Venture Market
• Biotech company is focused on developing medical devices for the pharmaceutical and nutraceutical fields and marketing its high-grade line of hemp cannabidiol (CBD)

Earth Science Tech, Inc. (OTC: ETST) recently released an audio press release discussing its future financial plans and its previously announced completion of audits and Form 10 submission, which could lead to an uplisting to the OTCQB Venture Market (http://cnw.fm/Fvs2f).

ETST has completed its audit for FY2015 and FY2016 and submitted its Form 10 to be fully reporting (http://cnw.fm/3kYLe), and it is currently conducting its audit for FY2017. That audit and the approved Form 10 submission, together, are needed for an uplisting to the OTCQB Venture Market.

ETST, a biotech company based in Doral, Florida, has repositioned its line of full-spectrum cannabidiol products. It also conducts R&D for low cost, non-invasive medical devices, as it concentrates on manufacturing, marketing and distributing its cannabinoid products to the nutraceutical and pharmaceutical markets.

Dr. Michel Aube, CEO and chief science officer of ETST, said that transparency is a key tool in the expansion of the company’s business and maintaining the confidence of investors. In a news release, he added, “Since all of our amazing projects are ongoing with our partners, investor confidence will grow, and we will be able to complete our first big round of financing.”

Nickolas Tabraue, director and president of ETST, said, “Thanks to our passionate, likeminded team, the transition should be smooth as we continue growing. I look forward to sharing updates on the full reporting process as it progresses.”

ETST holds four wholly owned subsidiaries. Cannabis Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures and distributes in the recreational sector. Earth Science Foundation, Inc. is becoming a non-profit to accept grants and donations for conducting additional studies. Earth Science Pharmaceutical develops medical diagnostic tools and vaccines.

For more information, visit the company’s website at www.EarthScienceTech.com

More from CannabisNewsWire

• ChineseInvestors.com, Inc. (CIIX) Subsidiary Expands Sales Force to Grow Division’s Domestic Revenues
• Medical Cannabis Payment Solutions (REFG) is Growing
• Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Places Bet in Oregon as CBD Goes Up and THC Goes Down

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

$SNNVF SeriousTraders Puts Spotlight on Sunniva

$CIIX Subsidiary Expands Sales Force to Grow Division’s Domestic Revenues

• ChineseInvestors.com is the foremost financial information website for Chinese-speaking investors
• The company provides premier, real-time market commentary, analysis and educational services in the Chinese language
• ChineseInvestors.com’s wholly owned subsidiary is ChineseHempOil.com, Inc.

California-based ChineseInvestors.com, Inc. (OTCQB: CIIX) operates the foremost financial information website for Chinese-speaking investors. A fintech company, ChineseInvestors.com provides online financial information in Chinese language character sets. This includes traditional and simplified character sets. This financial information is for the Chinese population in the United States and around the world. The company’s subscriber base includes free as well as paying members, mainly located in the United States and Canada.

The emphasis today is on companies that can provide first-rate information that brings greater transparency to investors. The CFA Institute (http://cnw.fm/MAR5q) states that “the use of data and technology can result in a more effective and efficient overall financial reporting process in which investors… receive more transparent, better-quality information on a timely basis.”

ChineseInvestors.com works to provide better-quality information by focusing on making available premier, real-time market commentary, analysis and educational services in the Chinese language. A premier financial information company, its services are primarily delivered to U.S. public and private companies and U.S. residents and citizens. In addition, the company’s focus is on providing advertising and public relations-related support services, helping companies to better link to the large and growing Chinese community.

ChineseInvestors.com’s wholly owned subsidiary is ChineseHempOil.com, Inc., which offers CBD (cannabidiol) oil and hemp oil products. This subsidiary has expanded its domestic sales force and has appointed Nina Wang as its vice president of sales for its United States Consumer Retail/E-Commerce Division. This furthers the process to complete the spinoff of all of ChineseInvestors.com’s hemp-related assets. Wang joined ChineseHempOil.com in March of this year. Since then, she has hired a team of sales representatives centered on wholesale and consignment sales in the Los Angeles area.

In a news release, Warren Wang, ChineseInvestors.com’s chief executive officer, said, “With over 15 years sales and management experience, we look forward to the increased sales that will be generated through Mrs. Wang’s leadership as we are laying the groundwork to increase revenues in advance of the spin-off of all of the Company’s hemp related assets.”

Wang has more than 15 years’ sales experience in the financial services industry. She has over 10 years of experience as a merchant services sales manager at USA First Credit Card, Inc. Before that, she worked as a sales manager for Alliance Bank Card Services.

The spin-off of all of ChineseInvestors.com’s hemp-related assets was originally scheduled for May 31, 2018. The spin-off has been temporarily postponed as the company continues to develop its domestic sales channels.

For more information, visit the company’s website at www.ChineseInvestors.com

More from CannabisNewsWire

• Medical Cannabis Payment Solutions (REFG) is Growing
• Earth Science Tech, Inc. (ETST) Eyes Future Uplisting to OTCQB Venture Market
• Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Places Bet in Oregon as CBD Goes Up and THC Goes Down

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

$FRSX TinyGems Newsletter Feature

$VSQTF Portfolio Company FansUnite Closes Oversubscribed Private Placement

VANCOUVER, British Columbia, May 31, 2018 — Victory Square Technologies Inc. (“Victory Square” or the “Company”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) is pleased to announce portfolio company, FansUnite Entertainment Inc. (“FansUnite”), has raised $4,457,750 CAD in a private placement financing (the “Private Placement”) valuing FansUnite at over $17,000,000 CAD.

Victory Square incorporated FansUnite earlier this year in order to prepare for an arrangement to spin out the assets of its FansUnite division, which includes an operating subsidiary, FansUnite Media Inc. (acquired 2016). As a result of share issuances from the treasury of FansUnite for nominal consideration to management and market partners and to subscribers pursuant to the Private Placement, the Company’s interest in FansUnite has decreased from 100% to 48.55%. The Private Placement was undertaken as part of FansUnite’s strategy to maximize shareholder value, which includes going public in the fourth quarter of 2018.

FansUnite is focused on utilizing the benefits of blockchain technology to disrupt the sports, gaming, and entertainment industries. FansUnite’s current key offerings are:  the FansUnite Protocol – a protocol level standard for sports betting and sports data applications, built on the Ethereum blockchain;  the FansUnite Sportsbook – the first decentralized application leveraging the FansUnite Protocol, offering an industry low margin and social elements designed to encourage user collaboration; and subsidiary company FansUnite Media Inc. – a free to play social sports betting community designed to track and analyze results, collaborate with fellow members, and to place fantasy wagers with no monetary risk.

FansUnite is continuing to develop the FansUnite Protocol, Sportsbook, and other applications, and pursuing M&A activity in the sports, gaming and entertainment industries.

The United States Supreme Court ruling on May 14, 2018, allowing the legalization of sports betting on a state-by-state basis has created a significant new regulated sports betting market.  FansUnite’s welcoming of regulatory overview, the transparency inherent in blockchain technology, and the industry low margins that FansUnite has created will be a massive win for bettors and fantasy players alike.

“We’re extremely pleased with the impressive oversubscription of the FansUnite private placement,” said Shafin Diamond Tejani, Chief Executive Officer of Victory Square. “FansUnite is utilizing blockchain technology in an industry ripe for growth and have the opportunity to build a protocol that can significantly change the landscape of the sports betting and sports data industries,” said Diamond.

“This is a great milestone for our FansUnite Team,” said Darius Eghdami, Chief Executive Officer of FansUnite. “We’ve assembled a strong team with decades of experience in the sports betting industry and are excited to build a more efficient, transparent and regulated platform.”

Rounding out FansUnite’s executive team of Darius Eghdami, and Duncan McIntyre, Chief Operating Officer, FansUnite has engaged Graeme Moore as Chief Financial Officer. Graeme, a Chartered Professional Accountant, was previously the Controller at Traction on Demand, and lead the finance department of one of Canada’s Best Managed Companies.
http://www.canadianbusiness.com/lists-and-rankings/best-managed-companies/traction-on-demand/

For further information about the Company, please contact:

Investor Relations Contact – Prit Singh
Email: prit@victorysquare.com
Telephone: 905-510-7636

Media Contact – Howard Blank, Director
Email: howard@victorysquare.com
Telephone: 604-928-6066

ABOUT VICTORY SQUARE TECHNOLOGIES INC.
Victory Square Technologies is a blockchain-focused venture builder that funds and empowers entrepreneurs to implement innovative blockchain solutions. Victory Square portfolio companies are disrupting every sector of the global economy including Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. Victory Square has a proven process for identifying game-changing entrepreneurs and providing them with the partners, mentorship and support necessary to accelerate their growth and help them scale globally. For more information, please visit www.victorysquare.com.

ABOUT THE CANADIAN SECURITIES EXCHANGE (CSE)
The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004, the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets.

FORWARD-LOOKING INFORMATION
This news release contains “forward-looking information” within the meaning of applicable securities laws relating to the outlook of the business of Victory Square, including, without limitation, statements relating to future performance by any portfolio company of the Company, the impact of any portfolio company’s performance on the Company, the strategic direction of the Company, and the potential spin out of its FansUnite division and strategy thereof for going public. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as “believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans”, “continues”, “project”, “potential”, “possible”, “contemplate”, “seek”, “goal”, or similar expressions, or may employ such future or conditional verbs as “may”, “might”, “will”, “could”, “should” or “would”, or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical fact contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square. Although Victory Square believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

$PBIO PreEMT™ Platform Enhances Development of Biotherapeutic Protein Drugs

• Biologics offer novel ways of treating degenerative diseases like Alzheimer’s
• Biologics are one of the fastest-growing drug categories
• PreEMT™ technology improves quality, reduces cost of biologic manufacture

When we think of drugs, an image of potions in round-bottom flasks conjured up in labs comes to mind, or perhaps pills of one sort or another ingested with a sip of water, for about 90 percent of drugs currently in use have that profile. However, discovering that the human body will act as its own physician by dispensing protective proteins called antibodies to fight the toxins that bring on diseases has spurred efforts, naturally enough, to develop those proteins synthetically. This new class of biotherapeutic protein drugs, or biologics, tends to be more effective at combating pathological conditions with less side effects, since they mimic endogenously produced proteins, which target highly specific parts of the invader (antigens). Unfortunately, the production of biologics is easier said than done; it typically requires hundreds of process steps to assemble one of these complex biotherapeutic proteins. Therefore, it should come as no surprise that the PreEMT™ platform recently acquired by Pressure BioSciences Inc. (OTCQB: PBIO) is a welcome addition to biologic development.

The company recently announced the signing of an agreement with an international biopharmaceutical company to assess the potential of the PreEMT™ technology as the basis for a unique manufacturing process and as an enhancement to the quality of a key protein-based drug currently under development (http://nnw.fm/Yr5lG).

Many currently available drugs are synthesized chemically, with molecular structures that are “well defined and relatively simple” (http://nnw.fm/abUv6). Their simplicity makes them easy to produce and easy for the human body to assimilate. A good example is acetylsalicylic acid (ASA), the active ingredient in aspirin, which has a molecular weight of about 180 grams per mole. Generally, such drugs are swallowed in pill or liquid form before entering the gastrointestinal system and blood stream by diffusion through the intestinal wall. Once in the blood, they have access to the entire body, their tiny size allowing them to penetrate cell membranes easily.

Biologics, by contrast, are much larger compounds that mimic the complex endogenous proteins produced by the immune system. They are generally composed of hundreds of amino acids and may carry a weight as high as 150,000 grams per mole. Biologics will bind to the specific cell receptors associated with a particular disease. For example, monoclonal antibodies are adept at recognizing very specific structures on the surface of cells. This specificity means that healthy cells are not adversely affected, resulting in less side effects. This is one reason that treatment by biologics can be superior to regimens developed with traditional combinatorial chemistries.

Because of their complexity, the manufacture of biotherapeutic proteins is prone to errors, very often falling prey to aggregation and misfolding. Misfolding occurs when the normal, three-dimensional structure of a protein becomes distorted, which may lead the protein to aggregate, a result that is quite the opposite of the benign outcomes intended in the manufacture of biologics. Many pathological conditions occur naturally by misfolded proteins. The list includes Alzheimer’s disease, which affects about 10 percent of the adult population over 65 years old in North America, as well as Parkinson’s disease and Huntington’s disease. However, PBIO’s PreEMT patented technology could reduce the incidence of misfolding in manufacture.

“PreEMT results in the dissolution of protein aggregates, which may have a significant impact on the quality of protein drugs by improving protein activity, homogeneity, and stability, as well as by reducing undesirable immunogenic properties”, Dr. Alexander Lazarev, PBIO’s vice president of R&D, stated in a news release.

Richard T. Schumacher, president and CEO of PBIO, added “Importantly, should the PreEMT technology result in more efficient production of high quality protein-based therapeutics for any biopharmaceutical company developing new protein-based therapeutics, manufacturing-scale licenses have the potential to generate millions of dollars in annual royalty revenue for PBIO.”

The technology is likely to find application across a wide range of proteins in reducing aggregation levels in bulk or final formulations, thereby improving product safety. PreEMT is scalable, and it is expected to significantly reduce manufacturing costs.

The acquisition of the PreEMT technology gives PBIO a footprint in the very large and growing biologics contract research services sector. The company is also busily developing its recently patented Ultra Shear Technology (UST) platform. The scalable, pressure-based UST technology creates stable nanoemulsions of otherwise immiscible fluids. It can be used to extend the shelf life of homogenized dairy products without refrigeration, for example. All the while, PBIO continues its focus on its core product line that generated $2.2 million in 2017 revenue: the development of pressure cycling technology (PCT)-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications.

For more information, visit the company’s website at www.PressureBioSciences.com

More from NetworkNewsWire

• SmartCash Makes Crypto Easy with Usernames for Payment and Send-to-Email Feature
• Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF) Eyes China’s Electric Vehicle Battery Market
• Net Element’s (NASDAQ: NETE) Unified Payments Targets Multibillion-Dollar Events Industry with Integrated Payment Solution

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$NETE Integrated Payment Solution Targets Multibillion-Dollar Events Industry

• U.S. meetings and events industry generates more than $330 billion annually in direct spending and more than $845 billion in business sales
• Unified Payments’ solution significantly streamlines and simplifies event processing
• Solution enhances existing acceptance services with intelligent integration for point-of-sale systems, self-order kiosks, chargeback protection and multi-channel payment acceptance

In the United States, the meetings and events industry is continually expanding across all segments and is a driving force that supports almost six million jobs and pumps hundreds of billions of dollars into the nation’s economy. Recent data from the Events Industry Council indicates that this industry currently generates more than $330 billion in direct spending and over $845 billion in business sales annually.

Leading global technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) is establishing a foothold in this robust market with the launch of a brand new intelligent payment solution created specifically for the events industry.

Unified Payments, a subsidiary of Net Element, now offers a complete solution for event processing that enables merchants to maximize their sales, shorten their ticket lines and enhance the overall customer experience. The company’s unique solutions go into action the instant that ticket sales commence for an event, and the robust package offered by Unified Payments transforms event processing and makes it significantly simpler overall.

Unified Payments’ solution boosts existing acceptance services with intelligent integration for point-of-sale systems, self-order kiosks, chargeback protection and multi-channel payment acceptance. Program options like Fast Pass Funding, same-day funding, Zero Pay and the Complimentary Equipment Placement Program are offered to all events industry merchants throughout North America.

The Zero Pay program enables merchants to collect 100 percent of the sales revenue for their event through a cash payment discount for customers who pay by check, credit or debit card. This program includes free equipment rental, mobile point-of-sale, an optional e-commerce platform, same-day funding, an onsite technician and an analytics platform.

The Standard Plan offered to event merchants allows them to accept payments regardless of where a customer is located or how they are paying. With this plan, merchants can unify all payments and optimize the payment acceptance process. The Standard Plan includes free equipment rental, mobile point-of-sale, self-order kiosks, an optional e-commerce platform, an onsite technician, same-day funding and an analytics platform.

The feature-rich payment acceptance solutions now made available for event managers and merchants through Net Element and Unified Payments have the potential to revolutionize the way event transactions are processed. Additional information can be found at http://nnw.fm/LhTv9.

For more information, visit the company’s website at www.NetElement.com

More from NetworkNewsWire

• Pressure BioSciences Inc.’s (PBIO) Recently Acquired PreEMT™ Platform Enhances Development of Biotherapeutic Protein Drugs
• SmartCash Makes Crypto Easy with Usernames for Payment and Send-to-Email Feature
• Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF) Eyes China’s Electric Vehicle Battery Market

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$FRSX JGR Capital Initiates Coverage

NEW YORK, May 30, 2018 — via NetworkWire — JGR Capital, an independent equity research firm, announces it has initiated coverage on Foresight Autonomous (NASDAQ:FRSX), a development-stage technology company that develops powerful and mature proprietary stereoscopic technology used in the automotive industry.

The full report can be found here: https://www.jgrcap.com/foresight-autonomous/

Foresight Autonomous (“Foresight,” “FRSX” or the “Company”) is a development-stage technology company that develops stereoscopic technology derived from the field-proven security technology of its major shareholder, Magna BSP. The stereoscopic technology is an image processing concept that uses synchronized cameras to mimic human depth perception and deliver a 3D view. FRSX’s systems create and analyze 3D images in order to foresee possible collisions in roadway environments while also providing highly accurate real-time alerts with near-zero false alerts. ​The Company’s proprietary stereoscopic and quad-camera technology is based, in part, on intellectual property that it has transferred from Magna BSP. Magna’s field-proven security technology has been deployed for almost two decades in critical facilities worldwide, including borders, nuclear plants and airports. FRSX’s main products are:

• QuadSight System, a four-camera multi-spectral vision system featuring near-100% obstacle detection under all weather and lighting conditions and targeting the semi-autonomous and autonomous vehicle market.
• Eyes-On ADAS System, a stereo vision Advanced Driver Assistance System (ADAS) backed by advanced algorithms.
• Eye-Net V2X System, a cellular-based accident prevention system.

Foresight Autonomous is operating in a lucrative market, as the demand for ADAS is expected to increase over the next decade. Additionally, the company is diversifying by seeking international opportunities as well as leveraging its opportunities within the rail industry.

Key Report Highlights

• Top-down worldwide vehicle market is growing steadily with tremendous potential and demand in ADAS and autonomous driving technologies.
• FRSX rapidly develops automotive vision solutions for ADAS and semi/fully autonomous vehicles.
• Foresight emphasizes its IP patents and trademarks as well as core R&D, with over 450% YoY growth in the expenditures.

Disclosures pertaining to this Foresight Autonomous report can be found at www.jgrcap.com.

About Foresight Autonomous

Foresight Autonomous is an Israel-based automotive technology company engaged in the design, development, and commercialization of stereo/quad-camera vision systems based on three-dimensional (3D) video analysis, advanced algorithms and artificial intelligence for image processing and sensor fusion. FRSX develops systems for accident prevention, which are designed to provide real-time information about a vehicle’s surroundings while in motion. The Company targets two vertical markets, advanced driver assistance systems (ADAS) and autonomous/semi-autonomous vehicles, with its two key products of Eyes-On and QuadSight respectively. FRSX also develops and owns a cellular-based accident prevention system named Eye-Net. The Company is headquartered in Ness Ziona, Israel.

About JGR Capital

JGR Capital is an independent equity research firm with a focus on small-cap and pre-IPO companies under $2 billion in market cap. JGR Capital leverages a tech-forward approach to help these companies navigate the market by increasing visibility through equity research. With three locations worldwide, JGR Capital offers analyst coverage via a tech-forward, data-driven approach. Because our reports are based on facts, not recommendations, we are a reputable, trusted resource for investors. For more information, visit www.jgrcap.com

Disclosure

This press release may contain forward-looking statements, which involve risks and uncertainties. Actual results may differ significantly from such forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed in the “Risk Factors” section in the SEC filings available in electronic format through SEC Edgar filings at www.SEC.gov.

The research analysts principally responsible for this press release do not receive compensation that is based upon any specific investment banking services or recommendations and can be compensated based on factors relating to the overall profitability of the JGR Capital (“firm”). As of the date of research distribution, neither the firm nor the principal research analysts beneficially own 1% or more of any class of common equity securities for this issuer (including, without limitation, any option, right, warrant, future, long or short position).

The securities of the issuer(s) discussed in this press release may be unsuitable for investors depending on their specific investment objectives and financial position. Past performance is no guarantee of future results. This research does not constitute a personal trading recommendation or take into account the particular investment objectives, financial situation or needs of an individual reader of this report, and does not provide all of the pertinent information to make an investment decision.

Investor Contact

JGR Capital
www.jgrcap.com
Email: research@jgrcap.com
Phone: 646-688-3143

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$SNNVF Grand Opening of Medical Cannabis Clinic in Windsor, Ontario

Vancouver, British Columbia–(May 30, 2018) – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) wholly-owned subsidiary, Natural Health Services Ltd. (“NHS“), Canada’s largest referral network of medical cannabis patients to Licensed Producers (“LPs“) in Canada, is holding an open house for media and the public, today, Wednesday, May 30 at the grand opening of its clinic located at 7900 Anchor Drive in Windsor, Ontario. The facility is one of seven owned and operated patient-centric clinics operating in Alberta, Saskatchewan, Manitoba and Ontario.

NHS Logo

NHS clinics use a unique triage system that provides an uncompromising standard of care from full-time medical professionals across its clinics. NHS provides consultation, medical cannabis education and an introduction to the products and strains available through LPs across Canada. NHS clinics are staffed by physicians, nurses, educators and patient care representatives on-site.

“Consumers are increasingly turning to cannabis for relief from a broad range of medical conditions,” said Dan Vass, President, NHS. “Our clinics allow patients to come in and talk freely and openly with knowledgeable medical professionals who are equipped to recommend the appropriate strain and dose to ensure positive outcomes.”

Medicinal cannabis is increasingly recognized and used to safely treat symptoms related to a wide range of ailments.

The NHS Windsor clinic is accepting new patients. Booking is available at www.naturalhealthservices.ca.

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets — Canada and California — where we are committed to delivering safe, high-quality products and services at scale. Our vision is to become the lowest cost, highest quality cannabis producer in the markets we serve by building large scale purpose-built current cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

Sunniva operates through its wholly owned subsidiaries:

Natural Health Services Ltd. (“NHS“) — NHS owns and operates a network of 7 clinics in Canada specializing in medical cannabis under ACMPR. NHS connects patients with safe and effective medical cannabis products through LPs. NHS has in-house physicians and nurse practitioners specializing in the endocannabinoid system providing expert consultation, education, and recommendations for patients. NHS’ proprietary technology infrastructure assists physicians, patients and LPs to comply with the rules of Health Canada. NHS has more than 150,000 active medical documents outstanding and 95,000 active patients.

Sunniva Medical Inc. (“SMI”) — SMI is building the Sunniva Canada Campus, 740,000 square feet of purpose-built cGMP designed greenhouse facilities in British Columbia. The facility will produce pesticide free products and will convert trim to extracted products such as cannabis oil. The oil can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams. As the facility is not complete, revenue and costs are not known, therefore, profitability cannot be assured.

CP Logistics, LLC (“CPL“) — Through CPL, Sunniva has commenced construction of the Sunniva California Campus, state-of-the-art, purpose-built greenhouse facilities in Cathedral City, California. The Sunniva California Campus is planned in two phases and has been cGMP designed. Phase 1 is designed to be 325,000-square feet and Phase 2 will be 164,000 square feet. At this facility, it is estimated 30% of all product will be used for higher margin extracted products and all products will be produced free from the pesticides commonly used within today’s industry. As the facility is not complete, revenue and costs are not known, therefore, profitability cannot be assured.

Full-Scale Distributors, LLC (“FSD“) — FSD, through its brand, Vapor Connoisseur, is a provider of custom, private-label vaporizers and accessories. FSD currently serves the needs of over 80 brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative vaporization devices. Products are tailored to client needs, ensuring both safety and reliability and FSD will continue to provide these services in coordination with the large supply from both Sunniva Campuses.

For more information please visit: www.sunniva.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information:
Dr. Anthony Holler
Chairman and Chief Executive Officer

Investor Relations Contact:
George Jurcic
Manager, Investor Relations
587-430-0680
ir@sunniva.com

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$PVOTF Signs Exclusive Manufacturing Agreement with Bio V Pharma Inc.

VANCOUVER, May 30, 2018 – Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) (“Pivot” or the “Company”) is pleased to announce that it has signed an exclusive Contract Manufacturing Agreement (the “Agreement”) with Bio V Pharma Inc. (“BioV”) to manufacture, label, package and supply Pivot’s bio-cannabis product pipeline. BioV is a Quebec-based full-service manufacturer of pharmaceutical and nutraceutical products including vitamins, botanical products, food and veterinary supplements and specializes in capsules, tablets, liquids and semi-solids delivered in a variety of packaging formats.

The BioV management team has over 40 years of experience in product development and manufacturing and will produce Pivot’s entire bio-cannabis suite of products including BiPhasix™ topical creams and lotions, Thrudermic™ transdermal gels and lotions, Solmic™ 1% CBD oral solution, and “RTIC™” Ready-to-Infuse-Cannabis Powder presented in capsules, single-use sachets and bulk packages.

Pivot has engaged Cannabis Compliance Inc. (“CCI”) to apply to Health Canada for a Dealer’s License (“Dealer’s License”) under the Controlled Drugs and Substances Act (“CDSA”) and the Narcotic Control Regulations.  Pivot’s Dealer’s License will be attached to the BioV facility in Dollard-des-Ormeaux, Quebec, enabling the Company to perform research and development, process natural health products, store cannabis derivatives, as well as import and export cannabis oils, concentrates and approved derivatives. In addition, a DL will also allow the Company to formulate cannabis products in various dosage forms, strengths or package sizes to support future market research and product innovation opportunities.

Dr. Patrick Frankham, Pivot’s CEO, stated “We are excited to have chosen Bio V Pharma as our Canadian manufacturing partner at this important time in Pivot’s history. Consumers and regulators will demand high-quality products that are manufactured in cGMP facilities by a knowledgeable and experienced team. BioV has a track record of supplying retail pharmacy chains, including Shoppers Drug Mart and London Drugs, with products meeting the highest quality standards. We continue to execute on our business plan to monetize our platform technologies by commercializing our suite of premium, science-based cannabis products in key markets.”

Pivot is currently in discussions with several Canadian Licensed Producers to secure supply of pharmaceutical-grade cannabis oils and isolates and expects to finalize a Supply Agreement shortly. Upon receipt of a Dealer’s License from Health Canada, Pivot will be ready to market its differentiated portfolio of products to consumers in Canada and the EU.  The Company remains on target to generate revenue in Q4 2018 from its operations in California, Canada and select EU countries.

About Bio V Pharma Inc.

Bio V Pharma is a Canadian based full-service manufacturer of pharmaceuticals and nutraceutical products including vitamins, botanical products, and food supplements. With over 40 years of experience in product development and manufacturing, Bio V currently services North America, Europe & the Middle East and is internationally recognized for quality & service, meeting the most stringent compliance and documentation requirements. For more information please visit www.biov.ca

About Cannabis Compliance Inc.

Cannabis Compliance Inc. offers risk mitigation, due diligence and regulatory compliance for commercial cannabis producers and resellers around the world. We focus in the global market, and provide our clients with trusted and comprehensive solutions. CCI has extensive expertise in regulatory compliance, cultivation/horticulture, security designs/tender, facility designs/build-outs, quality assurance programs, import & export, staff recruitment and financial planning. CCI exists to empower the future leaders in the global cannabis industry. For more information please visit www.cannabiscomplianceinc.com

About Pivot Pharmaceuticals Inc.

Pivot Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Pivot’s wholly-owned medical cannabis products division, Pivot Green Stream Health Solutions Inc. (“PGS” or “Pivot Green Stream”), conducts research, development and commercialization of cannabinoid-based nutraceuticals and pharmaceuticals. Pivot’s wholly-owned U.S. subsidiary, Pivot Naturals, LLC, based in Costa Mesa, California, will manufacture and supply finished powderized cannabis products such as food additives, capsules, bulk powder and stick packs to the California market. PGS has acquired worldwide rights to “RTIC” Ready-To-Infuse Cannabis oil-to-powder technology, BiPhasix™ Dermal Drug Delivery platform technology (topical), Solmic Solubilisation technology (oral) and Thrudermic Transdermal Nanotechnology (transdermal) for the delivery and commercialization of cannabinoid, cannabidiol (CBD), and tetrahydrocannabinol (THC)-based products. For more information please visit www.PivotPharma.com

Cautionary Statement

Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as anticipate, believe, estimate, expect, intend, and similar expressions, as they relate to Pivot Pharmaceuticals Inc., Pivot Green Stream Health Solutions Inc., Pivot Naturals, LLC, Bio V Pharma Inc., or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, such as the failure to meet the conditions imposed by the CSE or other securities regulators, the level of business and consumer spending, the amount of sales of Pivot’s products, statements with respect to internal expectations, including with respect to the Dealer’s License, the competitive environment within the industry, the ability of Pivot to continue to expand its operations, the level of costs incurred in connection with Pivot’s expansion efforts, economic conditions in the industry, and the financial strength of Pivot’s customers and suppliers. Pivot does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.

$SNNVF Receives Confirmation of Readiness From Health Canada

VANCOUVER, British Columbia, May 29, 2018  — via NetworkWire – Sunniva Inc. (“Sunniva” or the “Company”) (CSE:SNN)(OTCQX:SNNVF), a North American provider of cannabis products and services, is pleased to announce a major milestone with the receipt from Health Canada of the Confirmation of Readiness (“COR”) for a License under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) for the Company’s wholly owned subsidiary, Sunniva Medical Inc. (“SMI”). This represents acceptance of our detailed application with the next step being an inspection upon site readiness in order to commence cultivation.

The license and the expected completion of the Sunniva Canada Campus will position the Company as a significant supplier to the rapidly growing Canadian cannabis market.  Sunniva previously announced a take or pay supply agreement with Canopy Growth Corporation (“Canopy”). Under the terms of the initial two-year agreement, which includes the distribution of Sunniva branded products, Canopy will purchase approximately 45% of Sunniva’s annual production capacity; representing 45,000 kgs of dried cannabis annually, commencing Q1 2019 or shortly thereafter. The agreement is subject to SMI receiving its license from Health Canada and completing the Sunniva Canada Campus.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/012f0adb-01e8-462a-a0d2-d930ef675403

The Company is also pleased to announce that SMI has received development approval from the Regional District of Okanagan-Similkameen for construction of the Sunniva Canada Campus, which commenced at the beginning of May, on its previously announced purchased 126-acre site in Okanagan Falls, British Columbia.  Sunniva is currently finalizing the financing via bank and subordinate debt for the planned state-of-the-art 740,000 sq. ft. facility, designed to meet current Good Manufacturing Practice (“cGMP”) standards.

The Company is now focused on building the facility according to the design submitted.  Sunniva is leveraging its experience from their flagship greenhouse facility in California, which is already 5 months into the construction cycle.  In order to confirm readiness, SMI will be required to submit information including documentation, photos, and videos of the Sunniva Canada Campus presenting evidence of all physical security measures in order to receive a cultivation license from Health Canada.

Sunniva has chosen the following vendors in respect to the Sunniva Canada Campus project:

• Certhon Projects B.V. – supplier of the greenhouse superstructure, electrical, irrigation systems, lighting system and heating, cooling and CO² systems.
• EllisDon Corporation – engineering, construction manager and general contractor.
• MQN Architects – architect consultant.
• Urban Systems Ltd. – civil and landscape engineers.

“We are pleased to deliver on another key corporate milestone for the Company as we have made an excellent start to 2018 with significant progress on multiple fronts, executing on our strategy, and working toward our goal of creating one of the most efficient, low-cost growing operations to serve the Canadian and California cannabis market,” said Dr. Anthony Holler, CEO, Sunniva. “It is our intention to forward sell an additional 30% of our production capacity in Canada”.

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California – where we are committed to delivering safe, high-quality products and services at scale. Our vision is to become the lowest cost, highest quality cannabis producer in the markets we serve by building large scale purpose-built current cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

Sunniva operates through its wholly owned subsidiaries:

Sunniva Medical Inc. (“SMI”) – SMI is building the Sunniva Canada Campus, 740,000 square feet of purpose-built cGMP designed greenhouse facilities in British Columbia.  The facility will produce pesticide free products and will convert trim to extracted products such as cannabis oil. The oil can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams. As the facility is not complete, revenue and costs are not known, therefore, profitability cannot be assured.

CP Logistics, LLC (“CPL”) – Through CPL, Sunniva has commenced construction of the Sunniva California Campus, state-of-the-art, purpose-built greenhouse facilities in Cathedral City, California. The Sunniva California Campus is planned in two phases and has been cGMP designed. Phase 1 is designed to be 325,000-square feet and Phase 2 will be 164,000 square feet. At this facility, it is estimated 30% of all product will be used for higher margin extracted products and all products will be produced free from the pesticides commonly used within today’s industry. As the facility is not complete, revenue and costs are not known, therefore, profitability cannot be assured.

Natural Health Services Ltd. (“NHS”) – NHS owns and operates a network of 7 clinics in Canada specializing in medical cannabis under ACMPR. NHS connects patients with safe and effective medical cannabis products through LPs. NHS has in-house physicians and nurse practitioners specializing in the endocannabinoid system providing expert consultation, education, and recommendations for patients. NHS’ proprietary technology infrastructure assists physicians, patients and LPs to comply with the rules of Health Canada. NHS has more than 150,000 active medical documents outstanding and 95,000 active patients.

Full-Scale Distributors, LLC (“FSD”) – FSD, through its brand, Vapor Connoisseur, is a provider of custom, private-label vaporizers and accessories. FSD currently serves the needs of over 80 brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative vaporization devices. Products are tailored to client needs, ensuring both safety and reliability and FSD will continue to provide these services in coordination with the large supply from both Sunniva Campuses.

For the latest videos and photos of the Sunniva Canada Campus and further information regarding the Company please visit: www.sunniva.com

Neither Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding Sunniva’s plan to cultivate, produce and distribute a broad range of solutions focused on patients’ needs and Sunniva’s plans, timing and estimates for its facilities, are “forward-looking statements.” Forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Sunniva’s continuous disclosure documents available on www.sedar.com. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements. Although Sunniva has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Sunniva assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

Contact Information:
Dr. Anthony Holler
Chairman and Chief Executive Officer

Investor Relations Contact:
George Jurcic
Manager, Investor Relations
587-430-0680
ir@sunniva.com

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$HMMR Plans to Launch IaaS, Cloud Hosting Platform

• New Jersey-based communications company announces LOI marking “ideal combination of intellectual property”
• Company’s new IaaS cloud service plans support blockchain and cryptocurrency mining enterprises
• Hammer aims to position itself as a leader in future 5G technology

An agreement announced on May 8 by Hammer Fiber Optics Holdings Corp. (OTCQB: HMMR) to acquire the stock of 1stPoint Communications, LLC and its subsidiaries represents Hammer’s first acquisition, and furthers Hammer Fiber Optics’ plans to expand its wireless Internet, television, voice and fiber optic carrier services as it considers growing from its New Jersey, New York and Pennsylvania base of operations toward a national network (http://nnw.fm/x3VgV). The acquisition brings important revenue and EBITDA into the model.

Hammer Fiber Optics Holdings’ mission is to spearhead a change in the way television, Internet and phone services are delivered to entertainment-hungry consumers, and the company, doing business as Hammer Communications, is aligning itself with other businesses that embrace the same ideals as their core strengths.

Business models within the wireless, cable TV and media industries are changing as rapid technological advancement drives a convergence of the industries and redefines their parameters, joining their services together in one platform. Wireless networks are a primary catalyst of the overall industry transition (http://nnw.fm/RW6fJ).

The letter of intent for acquisition of 1stPoint Communications, LLC and subsidiaries Open Data Centers, LLC and Endstream Communications, LLC is “an ideal combination of intellectual property,” 1stPoint Communications CEO Erik Levitt stated in a news release. “Hammer will not only have the benefit of the exclusive rights to the patented AIR wireless technology but also to 1stPoint’s switching technology, its underlying CLECs (competitive local exchange carriers) and its Commercial Mobile Radio Services operator.”

In addition, the Open Data Centers facility in New Jersey, which includes its server and switching platforms, is “a significant addition to our core infrastructure to support major growth in the cloud and hosting markets,” Hammer’s founder, Mark Stogdill, stated in the news release.

The company recently revealed plans to launch a cloud hosting and infrastructure-as-a-service platform (IaaS) that offers hosting, cloud and colocation services for blockchain-interested enterprises. Data centers and the energy necessary to use them for cryptocurrency mining can require enormous overhead expenses of businesses, but Hammer’s best-in-class computer servers are prepared to deliver a cloud-based system to those small crypto businesses and free them from the constraints of building and maintaining their own corporate data centers.

Hammer currently serves residential and small businesses in its core market region by supplying high-capacity broadband, voice and video through cabled fiber as well as through its wireless fiber platform. As Hammer adds wholesale services such as backhaul support for cellular network operators, the company expects to position itself as a leader in future 5G technology.

Hammer is leveraging its systems to deliver high-capacity broadband to markets across the country at much lower cost than traditional methods. Live field testing of the new system begins this year with commercial service to follow in the coming months.

In January, the company also announced the launch of a virtual private network service (VPN) to accommodate clients’ concerns about privacy in their Internet usage, one of several ways Hammer is building its infrastructure and carrier grade services.

“We wanted to make sure that our customers had a way to connect and surf the internet away from the scrutiny of internet service providers, even ourselves,” Daniel Corbe, the director of Network Operations, stated in a news release. “Recently, the monitoring of internet usage and potential restriction on that usage have created a demand for customers to maintain their freedom.”

For more information, visit Hammer’s website at www.HammerCorp.info

More from NetworkNewsWire

• PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Adding Value to Nature-Identical Therapies Portfolio
• American-Swiss Capital, Inc. Taps Undervalued Seaside Investments as Tourists Flock to Stunning Montenegro
• Consorteum Holdings, Inc. (CSRH) Provides Platform to Bridge the Mobile Divide

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$ETST Continues to Develop High Grade Hemp-based Products to Meet CBD Growth

• CBD segment projected to grow to $2.1 billion by 2020
• Global hemp-based foods market forecast to grow at a CAGR of 24 percent from 2018 to 2022
• ETST uses cutting-edge technology to produce the highest-grade full spectrum hemp oil for product formulation

The CBD segment is one of the main drivers of the huge growth in the cannabis industry, with the Hemp Business Journal projecting this segment to grow to $2.1 billion by 2020 (http://cnw.fm/JPN3q). In addition, market research analysts Technavio forecast that the global hemp-based foods market will grow at a CAGR of over 24 percent through 2021 (http://cnw.fm/R2rcU). Earth Science Tech, Inc. (OTC: ETST) is an innovative biotech company with a primary focus on delivering high grade hemp-derived, cannabidiol (CBD)-based products to this market. It has a further focus on the development of diagnostic tools, testing processes and medical devices.

The company uses the latest supercritical CO2 cold liquid extraction method to produce the highest quality and purity full spectrum hemp oil, which is neither synthetic nor an isolate. ETST’s range of high grade cannabinoids extracted during this process contain a variety of valuable phyto-nutrients, essential oils and other naturally occurring therapeutic compounds found in the hemp plant. These are used to develop and commercialize products for the pharmaceutical and nutraceutical markets.

The company is the top brand for nutritional and dietary supplements in the industrial hemp market. ETST’s high grade CBD-rich hemp oil is classified as “food based” and is permissible in all 50 U.S. states and around 40 countries. It is used in the formulation of a wide range of CBD-infused products, including vitamins, minerals, herbs, botanicals, homeopathies, personal care products and functional foods. The company delivers its products in a variety of forms, such as capsules, soft gels, tablets, chewables, liquids, creams, sprays and powders.

ETST operates through several wholly owned subsidiaries:

• Cannabis Therapeutics, Inc. is an emerging biotechnology company that’s poised to become a world leader in cannabinoid research and development for a broad line of cannabis and cannabinoid-based pharmaceuticals and nutraceuticals, as well as other products and solutions.
• Earth Science Pharmaceutical, Inc. is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections (STIs) and diseases (STDs).
• KannaBidioid, Inc. is focused on the manufacture and distribution of vapes/e-liquids and gummy edibles in the recreational space, formulated using its unique Kanna and CBD formula.

In addition, the company established a Canadian subsidiary, Canna Inno Laboratories Inc., in 2017 to give it a foothold in the Canadian cannabis market. Based in Montreal, Quebec, Canna Inno received a grant from the Government of Quebec in March 2018 to fund its innovation drive in the pharmaceutical industry. This grant will be used for the pre-launch of three of ETST’s CBD-based patented nutraceutical products to fight breast cancer and neurodegenerative disorders. The company plans to apply for more grants under the Canadian government’s Scientific Research and Experimental Development Tax Credit program.

ETST has listed several of its products for sale on its website, including raw and flavored High Grade Hemp CBD Oil tinctures, CBD veggie capsules and e-liquids in six flavors. Customers can purchase single and bulk tinctures, bulk wholesale oil, powder, vape oil and other formulations for health and wellness.

For more information, visit the company’s website at www.EarthScienceTech.com

More from CannabisNewsWire

• PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Adding Value to Nature-Identical Therapies Portfolio
• Organic Cannabis Producer The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) Setting New Industry Standard for Low-Cost Production
• Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Targeting Growing CBD Pet Market with New Product Line

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

$CIIX Cannabis and CBD Markets are Set to Increase in Value

NEW YORK, May 29, 2018

According to a report by Hexa Research, the U.S. medical cannabis market is projected to reach $19.48 billion by 2024. The projected growth is driven by the increasing acceptance of medical advantages associated with cannabis, particularly for patients dealing with cancer, diabetes and chronic pain. Symptoms and conditions that may be treated with cannabis products include cancer, HIV, AIDS, Alzheimer’s disease, and multiple sclerosis. Chronic pain accounted for 46 percent of the U.S. cannabis medical market share in 2016. According to the research, the solid cannabis edibles segment in 2016, within the U.S. market generated $2.47 billion in revenue and is expected to continue to dominate the cannabis industry to 2024. Chineseinvestors.com, Inc. (OTC: CIIX), Kush Bottles, Inc. (OTC: KSHB), General Cannabis Corporation (OTC: CANN), Isodiol International Inc. (OTC: ISOLF), PotNetwork Holdings, Inc. (OTC: POTN)

A major portion of the legal cannabis industry Cannabidiol products. Cannabidiol, or CBD, is one of at least 113 active cannabinoids identified in cannabis. The CBD market is growing rapidly in recent years due to CBD’s medical benefits. Sean Murphy, the Founder and Publisher of Hemp Business Journal, said: “Hemp Business Journal estimates the total retail value of all hemp products sold in the U.S. to be at least $688 million for 2016. We estimate the hemp industry will grow to $1.8 billion in sales by 2020, led by hemp food, body care, and CBD-based products. The data demonstrates the hemp industry is growing quickly at 22% five year CAGR and being led by food and body care products, with Hemp CBD products showing a 53% AGR.”

Chineseinvestors.com, Inc. (OTCQB: CIIX) last week announced that, “its wholly owned subsidiary, ChineseHempOil.com, Inc. (“ChineseHempOil”) has expanded its domestic sales force appointing Nina Wang Vice President of Sales for its United States Consumer Retail/E-Commerce Division on March 19, 2018, setting the stage to complete the temporarily postponed spin off of all of the Company’s hemp related assets in the near future.

Mrs. Wang has over 15 year’s sales experience in the financial services industry with over 10 years as a Merchant Services Sales Manager at USA First Credit Card, Inc. Prior to that, Mrs. Wang worked as a Sales Manager for Alliance Bank Card Services. Since joining ChineseHempOil.com, Inc. in March 2018, Mrs. Wang has hired a team of sales representatives focused on wholesale and consignment sales in the Los Angeles area.

Through her efforts, ChineseHempOil.com, Inc. has developed strategic relationships with over 70 retail establishments in the Los Angeles area to consign the ChineseHempOil OptHemp products with plans to expand to Northern California in the near future. Mrs. Wang will also play an integral role in procuring new manufacturing relationships to, continuing to brand the Opt Hemp product line and developing new cutting edge hemp products.

“With over 15 years sales and management experience, we look forward to the increased sales that will be generated through Mrs. Wang’s leadership as we are laying the groundwork to increase revenues in advance of the spin-off of all of the Company’s hemp related assets. We were pleased with the 57% increase in monthly sales generated by the recent Mother’s Day Promotion and are looking forward to an even better response for the Father’s Day promotion” said Warren Wang CEO.

The Company recently announced in an 8k filing that spin-off of all of the Company’s hemp related assets, originally scheduled for May 31, 2018, has been temporarily postponed as it continues to develop its domestic sales channels.”

Kush Bottles, Inc. (OTCQB: KSHB) is a dynamic sales platform that provides unique products and services for both businesses and consumers in the cannabis industry. Earlier this month, the company announced it has partnered with MainStem, a technology-based ancillary product distribution company for the regulated cannabis industry, to be the inaugural partner for MainStem’s Vendor Program (MVP). Through its partnership with MainStem, Kush Bottles will be able to tap into the dedicated MainStem customer base to distribute its ancillary cannabis products through a centralized sales platform that users can access directly from the ‘BiotrackTHC’ software, a leading seed-to-sale compliance software, they use to run their businesses.

General Cannabis Corporation (OTCQB: CANN) is the comprehensive resource for the highest quality service providers available to the regulated Cannabis Industry. On May 14, 2018, the company announced financial results for the quarter ended March 31, 2018. Robert Frichtel, Chief Executive Officer of General Cannabis, said: “General Cannabis announced first quarter financial results today. For the first quarter of 2018, we reported revenues of $942,482, a 31% increase over 2017 first quarter revenues of $719,105. Our existing operations in Colorado continue to prosper with Security, Marketing and Operations segments each showing strong year-over-year revenue growth. The team and infrastructure we have built allows us to scale with the continued expansion within cannabis industry.”

Isodiol International Inc. (OTC: ISOLF) is a global CBD innovator specializing in the development of pharmaceutical and health and wellness products and now supporting the pharmaceutical industry at large with its recently approved CBD as an Active Pharmaceutical Ingredient. Recently, the company announced that it has signed a Letter of Intent (“LOI”) with Sundial Growers Inc., a privately held Alberta-based Health Canada ACMPR-approved licensed producer of medical cannabis, to import CBD isolate into Canada, subject to applicable regulatory approvals. Sundial currently operates a 31,000 square foot production facility in Rocky View, Alberta, and has two separate production facilities in various stages of completion and licensing. By 2020, it expects to be one of the leading cannabis companies in the country with a projected production of over 100 million grams of dry cannabis and the ability to process over 32 million grams of cannabis extracts.

PotNetwork Holdings, Inc. (OTC: POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils. On May 17, 2018, the company announced that it’s wholly owned subsidiary, Diamond CBD, Inc. was showcased at Booth 65 at the Atlantic City Convention Center, where 25,000 samples of its most popular CBD infused assorted gummy bears, were enjoyed by an international crowd of counter-culture exhibitors, consumers, and vendors. Diamond CBD has a highly successful history of sales from these key trade shows. At this show the Company featured numerous products, drawing attention directly from prospective vendors on a global scale. Featured at the show were Diamond CBD’s Vape Additives, Liquid Gold Vape Juice, Chill CBD Gummies, Diamond CBD Tinctures and Biotech Creams, the Company’s most successful products.

Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For chineseinvestors.com Inc. financial news dissemination and PR services, FinancialBuzz.com expects to be compensated three thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com has signed a two year agreement with chineseinvestors.com Inc. for one hundred thousand restricted common shares for continued financial news dissemination and PR services. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.

Media Contact:
info@financialbuzz.com
+1-877-601-1879

Url: http://www.FinancialBuzz.com

$SNNVF to Announce 2018 First Quarter Results on May 30, 2018

VANCOUVER, B.C., May 25, 2018 — via NetworkWire – Sunniva Inc. (“Sunniva” or the “Company“) (CSE:SNN) (OTCQX:SNNVF)  plans to release its results for the first quarter 2018, after market close on Wednesday, May 30, 2018.

The Company’s executive management will discuss the results during a conference call on Thursday, May 31, 2018 at 11:00 am Eastern Time/8:00 am Pacific Time. To participate in the call, please dial 1-800-319-4610, or (604) 638-5340. An audio replay will be available shortly after the call by dialing 1-855-669-9658 or (604) 674-8052 and entering access code 2365. The replay will be available for two weeks after the call.

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – where we are committed to delivering safe, high-quality products and services at scale. Our vision is to become the lowest cost, highest quality cannabis producer in the markets we serve by building large scale purpose-built current Good Manufacturing Practices greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

For more information please visit: www.sunniva.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information:
Dr. Anthony Holler
Chairman and Chief Executive Officer

Investor Relations Contact:
George Jurcic
Manager, Investor Relations
587-430-0680
ir@sunniva.com

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com